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ACH  Air Changes per Hour 
CFU  Colony Forming Units 
CoNS  Coagulase Negative Staphylococci  
CRP  C-Reactive Protein 
CV  Conventional mixing Ventilation 
DAIR  Debridement, Antibiotics and Implant Retention 
DTT  Difficult-To-Treat 
ESR  Erythrocyte Sedimentation Rate 
HEPA   High-Efficiency Particulate Air 
LAF  Laminar Airflow 
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MRSE  Methicillin Resistant Staphylococcus Epidermidis 
NAR  Norwegian Arthroplasty Register 
PCR  Polymerase Chain Reaction  
PJI  Prosthetic Joint Infection 
SSI  Surgical Site Infection 
THA  Total Hip Arthroplasty 
UDF  Unidirectional Airflow 
VFR  Volume Flow Rate 
WBC  White Blood cell Count 
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Each year approximately 7,000 patients receive a total hip arthroplasty (THA) in 
Norway. The most common indication is osteoarthritis and most patients experience 
substantial pain relief postoperatively. A rare but much feared complication after 
arthroplasty surgery is postoperative prosthetic joint infection (PJI). This is a huge 
burden for patients and a technical challenge for surgeons, generating huge costs for 
the health care system and society. Knowledge of how and why these infections arise 
is essential in order to provide the best possible prophylaxis against and treatment of 
PJI. The aim of the first part of this thesis was to assess what kind of bacteria cause 
revisions due to infection after THA (Paper I). We also wanted to assess correlations 
between bacteriology and haematological findings (Paper I) and antibiotic resistance 
amongst the bacteria found in THA revisions due to infection (Paper II).  
We used the Norwegian Arthroplasty Register (NAR) and supplemented this with 
bacteriological findings including antibiotic resistance patterns and preoperative blood 
samples including parameters of infection, collected from patient records. As expected, 
we found a large proportion of Staphylococci, a commensal organism known to be part 
of normal human skin flora. Coagulase negative staphylococci (CoNS) showed 
increased resistance to several antibiotics that are used both as prophylaxis and in 
empirical and definitive treatment of PJI. As the staphylococcus aureus (S. aureus) 
species led to significantly higher biochemical parameters of infection compared to 
CoNS, our results might inform the choice of empirical treatment based on 
haematological status in cases of arthroplasty infection with an unknown causative 
pathogen. 
In the second part of the thesis (Papers III and IV), we wanted to enhance 
understanding of the origin of these infections by assessing operating room ventilation 
as a prophylactic measure against revision due to infection. The air in the operating 
room is, in addition to other surgery- and patient-related factors, a possible risk factor 
for postoperative infection. In Norwegian hospitals there are mainly two ventilation 
principles that are used to increase the cleanliness of the air: conventional, turbulent, 
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mixing ventilation (CV) and unidirectional airflow (UDF) ventilation, formerly known 
as laminar airflow (LAF) ventilation, where the latter has in recent years been 
recommended on a disputed scientific basis. Lack of evidence for reduction in 
postoperative infection has led to the implementation of UDF systems being questioned 
as a prophylactic measure against postoperative infection. The NAR holds surgeon-
reported data on the type of ventilation used during primary THA. We validated these 
ventilation data by performing a comprehensive assessment of the historical and 
present ventilation systems in 40 hospitals in Norway during the period 1987-2015 
(Paper III). This was done in cooperation with knowledgeable surgeons and engineers 
at the relevant hospitals. This assessment showed that not all surgeons knew exactly 
what kind of ventilation system they performed the THA in, and accordingly may have 
reported inaccurate data to the register. This might have led to erroneous conclusions 
in earlier register studies on this topic. A series of such studies using data on ventilation 
reported by the surgeon or surgical department contributed to the scientific basis for a 
report on infection reduction from the World Health Organization (WHO) from 2016. 
This report concluded that UDF systems should not be installed in new operating rooms 
where arthroplasty is performed.  
We continued the project by conducting new analyses on the risk of revision due to 
infection after THA using validated ventilation data (Paper IV). This included sub- 
analyses of technical specifications of the different systems. We concluded that UDF 
systems do not increase the risk of infection, as recent literature seems to imply. By 
performing a sub-classification based on technical specifications, we show that there is 
substantial variation between the different UDF systems and that the more modern and 
large UDF systems, offering high volumes of air, show a slight reduction in the risk of 
revision due to infection after THA compared to CV. This is in concordance with other 
studies showing that UDF/LAF systems are able to create cleaner air than CV systems.  
When taking our results into account, considering also the finding of increased 
antibiotic resistance amongst common causative bacteria of THA, it would be 
erroneous to discontinue the use of large, high volume, vertical UDF systems in the 
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operating room of the future. We hope and believe that the results of this thesis will 
have an impact on the ongoing international discussion on operating room ventilation 




Hvert år opereres omtrent 7,000 pasienter med total hofteprotesekirurgi (THA). Den 
vanligste indikasjonen er artrose (slitasjegikt), og de aller fleste opplever bedret 
funksjon i etterkant. En sjelden, men fryktet komplikasjon etter protesekirurgi er 
infeksjon. Dette er en stor belastning for pasientene, en teknisk utfordring for kirurgene 
og en meget kostbar hendelse for helsevesenet og samfunnet. For å kunne gi pasientene 
den best mulige profylakse og behandling mot proteseinfeksjon er det essensielt å ha 
kjennskap til hvordan og hvorfor infeksjonene oppstår. For å kunne bidra til økt 
forståelse ønsket vi i det første delprosjektet å kartlegge hvilke typer bakterier som 
fører til infeksjon etter innsetting av totale hofteproteser (Artikkel I). I tillegg ville vi 
se om vi fant noen korrelasjon mellom bakteriefunn og hematologiske 
infeksjonsparametere (CRP og SR) (Artikkel I), og i tillegg vurdere forekomst og 
eventuell endring av antibiotikaresistens blant bakteriene (Artikkel II).  
Vi tok utgangspunkt i data fra Nasjonalt Register for Leddproteser (NRL) som vi 
supplerte med bakteriologiske prøvesvar fra sykehusjournaler, inkludert antibiotiske 
resistensbestemmelser og preoperative blodprøvesvar, inkludert infeksjonsparametere. 
Som forventet fant vi en stor andel av stafylokokker. Dette er bakterier som er en vanlig 
bestanddel av menneskers normale hudflora. De hvite stafylokokkene viste økt 
resistens mot flere typer antibiotikum som brukes både i behandling og forebygging av 
proteseinfeksjon. Gule stafylokokker gav signifikant høyere infeksjonsparametere enn 
hvite stafylokokker, og i Norge kan derfor disse resultatene gi støtte til valg av empirisk 
behandling i tilfeller med ukjent bakterie, men kjent blodprøvestatus. 
I det andre delprosjektet ønsket vi forsøksvis å belyse noe av forklaringen på hvor slike 
infeksjoner har sitt opphav, ved å se på effekten av operasjonsstueventilasjonen som et 
forebyggende tiltak mot proteseinfeksjon (Artikkel III og IV). Luften i operasjonssalen 
er sammen med andre pasient- og operasjonsrelaterte faktorer, antatt å være en 
risikofaktor for postoperativ infeksjon. I norske sykehus er det hovedsakelig to 
ventilasjonsprinsipper som brukes for å bedre renheten av luften: Konvensjonell, 
turbulent blandingsventilasjon (CV) og unidireksjonell luftrømsventilasjon (UDF) 
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(tidligere kjent som laminær luftstrømsventilasjon (LAF)), hvor sistnevnte de senere år 
har vært anbefalt på et noe kontroversielt vitenskapelig grunnlag. Manglende bevis for 
reduksjon i insidens av postoperativ infeksjon har satt spørsmålstegn ved 
implementeringen av UDF-systemer som beskyttelse mot infeksjoner i nye 
operasjonsstuer. I NRL finnes det kirurgrapporterte data på hvilken type ventilasjon 
som ble brukt under primærinngrepet. Vi validerte disse dataene ved å gjøre en grundig 
gjennomgang av de aktuelle og historiske ventilasjonsforholdene på 40 inkluderte 
sykehus i perioden 1987-2015 (Artikkel III). Dette ble gjort i samråd med kirurger og 
ingeniører med kunnskap om ventilasjonssystemene på de aktuelle sykehusene. Denne 
gjennomgangen viste at kirurgene ikke var helt klare over hvilken type ventilasjon de 
faktisk opererte i. Dette kan ha medført at tidligere registerstudier gjort på den 
profylaktiske effekten av ventilasjonssystemer, kan inneholde feil. En rekke slike 
registerstudier med ventilasjonsdata rapportert fra kirurger eller kirurgiske avdelinger, 
bidro i 2016 til en ny rapport fra verdens helseorganisasjon (WHO) angående 
infeksjonsreduksjon. Denne konkluderer med at UDF-systemer ikke bør installeres i 
nye operasjonsstuer hvor protesekirurgi skal utføres. 
Prosjektet vårt ble videreført ved å gjøre nye analyser på risiko for revisjon på grunn 
av infeksjon etter THA med validerte ventilasjonsdata, inkludert subanalyser på ulike 
tekniske spesifikasjoner av ventilasjonssystemene (Artikkel IV). Alt i alt viser vi at 
UDF-systemer ikke øker faren for infeksjon, slik som nyere litteratur har antydet. Ved 
å gjøre en inndeling av UDF-systemene basert på tekniske spesifikasjoner, viser vi også 
at det er betydelige forskjeller mellom de ulike UDF-systemene hvor moderne, store 
systemer, som tilbyr høyt luftvolum, viser en viss reduksjon i revisjon pga infeksjon 
etter hofteproteseoperasjon sammenliknet med CV. Dette er i overensstemmelse med 
andre studier som viser at UDF-/LAF-systemer kan gi renere luft enn CV-systemer. 
Når man tar våre resultater med i betraktningen, sammenholdt også med funn av 
økende, antibiotisk resistensgrad blant de vanligste bakteriene som fører til infeksjon 
etter THA, synes det feilaktig å ikke implementere store, høyvolum vertikale UDF-
systemer i fremtidens operasjonsrom. Vi håper og tror at resultatene fra denne 
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avhandlingen vil bidra til den internasjonale diskusjonen angående 
operasjonsstueventilasjon og perioperativ håndtering av pasienter på operasjonsstuer 
hvor ultraren kirurgi foregår.  
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1 General background 
In total hip arthroplasty (THA) the injured or worn hip is substituted by an artificial 
joint. More than 7,000 patients receive a THA each year in Norway and the main 
indication is osteoarthritis. Most prostheses are made of surgical steel or various titan 
alloys, and together with occasional polyethylene inserts and bone cement they 
constitute a large foreign body that is introduced into a presumptive sterile, biological 
environment. Such foreign bodies are subject to both adhesion of bacteria and the 
protective immune system of the host. The “race for the surface” is described in the 
literature as a struggle between the tissue integration process of the host and the 
colonization and biofilm formation of bacteria on the surface of the foreign body (1). 
If the bacteria win this race, a fulminant prosthetic joint infection (PJI) might develop. 
This is a much feared complication that in most cases necessitates reoperations and 
prolonged antibiotic treatment. For patients this involves prolonged hospital stays, loss 
of function due to repeated surgery, and potential complications of both the surgical 
and medical treatment. The mortality risk of patients with a revision for PJI is 
approximately double the risk of that in a reference population (2). The five-year 
pooled mortality is by some estimated to be around 20% (3), which is comparable to 
the pooled mortality of colorectal cancer and uterine cancer (4). Further, it is estimated 
that an infected THA will cost up to four times more than uncomplicated primary THA 
(5, 6). 
Optimal prophylaxis against and treatment of PJI depends on knowledge of what 
causes the infection and from where the infection originates. This thesis aims to assess 
the bacteriology of PJI after THA, the antibiotic resistance patterns and the possible 
correlation between bacteriology and haematological infection parameters. A further 
aim is to assess the importance of air cleanliness indirectly by evaluating the ventilation 






1.1 Total hip arthroplasty 
In total hip arthroplasty the whole hip joint including the proximal femur and the 
articular acetabulum is substituted. A total hip prosthesis consists of a femoral stem, a 
head at the top of the stem and an acetabular cup substituting the acetabulum of the 
pelvis. Figure 1 shows a hip joint with osteoarthritis before and after THA. 
Osteoarthritis is the most common indication for THA with other indications being 
complications to inflammatory disease, hip fracture, complications after hip fracture, 
and complications after childhood hip disease, among others. The surgery is quite 
standardized with regards to patient handling, surgical approach, surgical technique, 
duration of surgery, etc. This makes THA favourable for comparative research. 
 
Figure 1: Osteoarthritis of the right hip before (A) and after (B) an uncemented THA  
 
There are many different producers and designs of hip prostheses, but basically two 
main principles of prosthesis design dominate (Figure 2). The most common one today 
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is the modular prosthesis where the stem and the head are separate parts. The acetabular 
cup may also be modular with a separate liner in a metal shell. In the monoblock 
prosthesis the stem and the head come in one piece, as also in the monoblock acetabular 
cup.  
 
Figure 2: Prosthesis concepts and methods of fixation (by courtesy of Geir Hallan) 
 
There are also two main principles of prosthesis fixation to the bone: with the use of 
bone cement or without (Figure 2). The uncemented prosthesis has a surface of either 
hydroxyapatite or titanium that allows growth of bone into the structure of the 
prosthesis. Combinations of fixation methods are also utilized, where the most common 
combination consists of a cemented acetabular cup and an uncemented femoral stem. 
This combination is called a reverse hybrid fixation. The combination of a cemented 
stem and an uncemented cup is referred to as a hybrid fixation, but is little used in 
Norway today.  
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1.2 Infection after total hip arthroplasty 
Postoperative infections after THA are often classified according to the time of 
symptom debut. This is a simple classification that is widely used, where early 
infections are defined as symptoms occurring <3 months following primary THA, 
while delayed refers to 3-24 months and late >24 months after primary THA (7, 8). 
This classification is based on several approximations: early infections are acquired at 
implantation with virulent bacteria leading to an acute presentation, delayed infections 
are acquired at implantation with less virulent bacteria causing a more subtle clinical 
presentation, and late onset infections are predominantly acquired by haematological 
seeding. 
A more clinically directed classification scheme was presented by Tsukayama in the 
1990s (9). This classification is also based partly on the time since prior implant 
surgery, as well as other clinical aspects, and divides arthroplasty infections into four 
categories. The first category, positive intraoperative culture, includes revisions due to 
presumed aseptic loosening where culturing of intraoperative tissue samples reveals 
microbial growth. Early postoperative infection occurs within one month of implant 
surgery with an acute presentation, while late chronic infection occurs after one month 
with a more insidious course. The last category, acute haematogenous infection, might 
appear at any time after implant surgery, presenting with an acute onset of symptoms 
and documented or suspected bacteraemia. 
There are numerous additional classifications used in different publications. Worth 
mentioning is the classification by McPherson (10), which also assesses different 
clinical aspects of PJI, but a further description of this is beyond the scope of this thesis. 
The different types of infection are often classified into two main groups: surgical site 
infection (SSI) and prosthetic joint infection (PJI). SSI after arthroplasty is divided by 
the Centres of Disease Control and Prevention (CDC) into three categories (11-13): 
superficial incisional SSI, which involves only skin and subcutaneous tissue of the 
incision, deep incisional SSI, which involves deep soft tissue of the incision, and 
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organ/space (bone/joint) SSI, which involves any part of the body deeper than the 
fascial/muscle layers that is opened or manipulated during the operative procedure.  
The criteria for PJI were postulated in the aftermath of the Philadelphia international 
consensus meeting held in 2013 (14), where delegates of 51 different nationalities and 
various disciplines came together to evaluate the available evidence. Based on the main 
criteria in the consensus report, PJI is defined as two positive periprosthetic cultures 
with phenotypically identical organisms, or a sinus tract communicating with the joint, 
or cases having three of the following minor criteria: 
 Elevated serum C-reactive protein (CRP)  AND erythrocyte sedimentation rate 
(ESR) 
 Elevated synovial fluid white blood cell (WBC) count, OR ++ change on 
leukocyte esterase test strip  
 Elevated synovial fluid polymorphonuclear neutrophil percentage  
 Positive histological analysis of periprosthetic tissue  
 A single positive culture 
 
THA revision due to deep infection 
The endpoint of postoperative infection in the NAR has been defined as THA revised 
due to presumed infection with the removal or exchange of parts or the whole of the 
prosthesis. The infection diagnosis is reported immediately after surgery by the surgeon 
based on perioperative assessments and clinical evaluation, and reported accordingly. 
From 2011 all reoperations due to infection were to be reported, including cases treated 
with debridement without the removal or exchange of parts. However, the operations 
included in this thesis only include revisions with removal or exchange of parts or the 
whole of the prosthesis due to deep infection.  
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1.3 Diagnostics of prosthetic joint infection 
The diagnosis of PJI is set by the surgeon based on clinical findings, haematology, 
radiology, and bacteriological assessments conducted pre- and/or peroperatively. As 
all investigations are of varying sensitivity and specificity, it is essential to perform a 
broad evaluation and to assess the situation accordingly. 
Depending on various patient-related factors and the virulence of the causative 
pathogen, the clinical presentation of PJI might vary from isolated pain as the only 
symptom, to more acute, severe infections with extensive soft tissue involvement and 
sepsis.  
The clinical findings can be supported by the evaluation of haematological infection 
parameters. The most commonly used parameters from blood samples are C-reactive 
protein (CRP), erythrocyte sedimentation rate (ESR) and white blood cell (WBC) 
count, the results of which also depend partly on microbial virulence (15). They have 
high sensitivity, and are cheap and easily accessible, but due to low specificity, these 
markers cannot be used alone in diagnostics of PJI (16, 17). Different biomarkers in 
blood serum such as D-dimer, interleukin-6 and procalcitonin have been proposed as 
substitutes in first line diagnostics of PJI, but they have not shown any significant 
increase in specificity (17). Different biomarkers in joint fluid like α-defensin and 
leukocyte esterase have also been proposed as substitutes due to increased specificity 
(18). But with joint aspiration being a much more invasive method than blood 
sampling, and as the sensitivity is lower, this has not been introduced as a standard. 
Conventional X-rays might provide support, especially in cases with a diffuse clinical 
presentation and sparse haematological findings, as in low grade infections with low-
virulence bacteria. The findings that an X-ray might reveal are osteolysis surrounding 
parts of the prosthesis and possibly periosteal reaction on the surrounding bone tissue 
(19, 20). Images must be interpreted in relation to other findings. These include prior 
radiology to evaluate possible progression as current images themselves can rarely 
distinguish between true infection and aseptic loosening. To evaluate soft tissue 
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involvement and periosteal reaction, a computed tomography (CT) scan might be a 
better alternative  (21).  
If the diagnosis remains unclear, preoperative aspiration with assessment of joint fluid 
with cell counts, bacteriological culturing, Gram staining or polymerase chain reaction 
(PCR) might be indicated (22-24). This might be valuable to help define the need of 
surgical intervention in cases of doubt, or to identify the causative pathogen in cases 
where antibiotic suppression treatment might be indicated. 
At revision, the recommendation is to take at least five tissue samples for 
bacteriological and histological examination. Despite this, the share of culture negative 
infection is substantial, often due to perioperative antibiotic treatment (25, 26). 
Sonication of the removed prosthetic parts with culturing and/or PCR of sonicate fluid 
might help to identify the causative pathogen (27, 28). 
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1.4 The microbiology of infected THA 
1.4.1 Bacteriology 
The main basis of optimal prophylaxis and treatment of PJI is knowledge of the 
microbiology and the causative pathogens (7). In the following, a short introduction to 
the bacteriology of hip PJI will be given. Each bacteria is initially presented by the way 
it appears in a Gram-stained smear under a microscope, either Gram-negative or Gram- 
positive, or if the bacteria appear as spherical cocci, elongated rods or as filamentous 
bacilli, appearing singularly or in couples, chains or clusters. 
 
Staphylococci 
Staphylococci are Gram-positive cocci often seen in clusters, which constitute a normal 
component of human skin and mucosal flora. Staphylococci are the most common 
bacteria in PJI and are the cause of 50-60% of prosthetic hip infections (29, 30). 
 
Staphylococcus aureus (S. aureus) are known to be more virulent than coagulase 
negative staphylococci (CoNS), mainly due to the production of bound or free 
coagulase enzymes (31). They usually lead to a more severe presentation and are often 
associated with severe, invasive infection. PJI caused by S. aureus often presents as 
acute or early infection (32), but may also appear later on with a more diffuse 
presentation (33). It is speculated that derivatives of S. aureus, so-called “small colony 
variants” might be the cause of both the change in presentation and resistance to 
treatment (34, 35). Such derivatives might evolve by mutations in metabolic genes, 
which gives sub-populations with a less virulent phenotype, but one that can remain 
viable within the host cells. 
CoNS is a group of staphylococci historically often evaluated as pollutants due to their 
relatively low virulence and prior difficulty of identification (36). For the same reason, 
the sub-groups of CoNS have not been studied in detail and they are often referred to 
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as one large entity. Unlike S. aureus they rarely lead to severe, invasive infection, as 
the most common route of infection is by foreign body adhesion and biofilm formation. 
Staphylococcus epidermidis (S. epidermidis) is the most common type of CoNS. Other 
sub-groups of CoNS known to cause PJI are S. simulans, S. caprae and S. lugdunensis. 
PJI with CoNS can occur at any time after THA, but is often found in delayed and late 
infections where pain might be the only symptom.  
S. lugdunensis differs from other CoNS in virulence and antibiotic resistance. They 
produce less β-lactamase and are therefore more susceptible to penicillins (37). They 
also have a bound form of coagulase and show greater virulence than other CoNS. 
Infections with S. lugdunensis might therefore mimic infections with S. aureus with a 
more acute presentation with pain and swelling  (38).   
 
Cutibacteria 
Cutibacterium acnes (C. acnes), formerly known as Propionebacterium acnes (P. acnes) 
are anaerobic Gram- positive rods that also constitute part of the normal skin flora, 
especially in areas with abundant sweat and sebaceous glands, such as the groin and 
the axilla (39). They are anaerobic and slow growers with a relatively low virulence, 
and the presentation is often mild with pain as the only symptom. Cases of C. acnes 
PJI are therefore often difficult to distinguish from aseptic loosening and as with CoNS, 
the identification of C. acnes has historically often been evaluated as pollution. 
 
Streptococci 
Streptococci are Gram-positive cocci that often occur in couples or chains. The main 
classification is the differentiation between α- and β-haemolytic streptococci 
depending on their ability to perform lysis on haemoglobin. α-haemolysis is a partial 
decomposition of the haemoglobin of the erythrocytes, whereas β-haemolysis leads to 
a complete breakdown of the haemoglobin. The β-haemolytic streptococci are further 
subdivided by surface antigens into A, B, C, D, F and G. The most common types of 
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streptococci found in PJI are α-haemolytic viridans streptococci and β-haemolytic 
group A (Streptococcus pyogenes), group B (Streptococcus agalactiae) and group G 
(Streptococcus dysgalactiae) streptococci, often due to bacteraemia from other 
infection foci in patients with comorbidity (40-42). The majority of streptococcal PJIs 
present as late, haematogenous infections with acute onset and invasive infection with 
pain and swelling (43). 
 
Enterococci 
Enterococci are also Gram-positive cocci in couples or short chains. For this reason, 
they might be difficult to distinguish from streptococci. Monomicrobial enterococci 
infection after THA has been sparsely studied in detail, but is thought to originate from 
haematogenous seeding from infections of the gastrointestinal or urinary tract (44). 
Enterococci are relatively low virulent and often lead to late infections with pain as the 
main symptom. Occasionally they are also seen as part of polymicrobial infections with 
a different clinical presentation (45). 
 
Enterobacteriaceae 
Enterobacteriaceae is a large family of Gram-negative rods where the most common 
one causing hip PJI is Escherichia coli (E. coli). They show a relatively high virulence 
that often leads to an acute presentation in early infection, and are often associated with 
polymicrobial infection (46). Enterobacteriaceae in the normal human flora are found 
in the gastrointestinal tract, and the proximity to the hip is proposed as a potential 
explanation for the higher proportion of enterobacteriaceae in infected THA relative to 
other types of infected arthroplasty (47).  
 
Other pathogens 
There are some other, rarer pathogens that will not be described in further detail in 
this thesis. These rare infections mainly occur in immunosuppressed patients or older 
patients with severe comorbidities. Worth mentioning here are anaerobic bacteria 
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such as bacteroides and peptostreptococci, fungi such as different types of candida, 




Many of the different bacteria are capable of biofilm formation. Biofilm is a protective 
matrix consisting of glycocalyx fibres, protecting the bacteria from the patient’s 
immune system in addition to any prophylaxis and/or antibiotic treatment. This might 
complicate the identification and treatment of biofilm-embedded bacteria (48). The 
bacteria encapsulated within the biofilm might also lead to a milder grade of infection 
compared to cases with free planktonic bacteria, which could result in a false diagnosis 
and insufficient treatment (8, 35). To increase the accuracy of the diagnosis, sonication 
of the removed implant has been proposed to make the biofilm bacteria available for 
culturing. But the method is disputed and has not been implemented as a standard in 
the diagnostics of arthroplasty infection in Norway (28).  
 
1.4.3 Antibiotic resistance 
The susceptibility of the bacteria to antibiotics is of utmost importance in curative 
treatment of PJI. Development of antibiotic resistance is a much feared problem 
worldwide and poses a growing challenge in the treatment of PJI (49). A brief summary 
of the most important trends of antibiotic resistance among the different bacterial 
groups will be presented in the following.  
Staphylococci 
A majority of staphylococci are producers of penicillinase, which makes them partially 
resistant to penicillins. In recent decades, staphylococci have also shown increased 
production of β-lactamase, and S. aureus has also shown increased resistance to 
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antibiotics in the methicillin group, including penicillinase-resistant penicillins and β-
lactam antibiotics including oxacillin, kloxacillin and dicloxacillin. These S. aureus are 
called methicillin-resistant S. aureus (MRSA) and constitute an increasing threat 
worldwide (50). The same trend is also seen amongst CoNS in the shape of methicillin-
resistant S. epidermidis (MRSE). Due to restrictive use of antibiotics and precautions 
regarding bacterial import as described by national guidelines (51), the proportion of 
MRSA/MRSE in Norway has traditionally been quite low, although the resistance 
seems to be evolving (52). 
 
Streptococci 
Streptococci have traditionally been quite sensitive to most kinds of relevant 
antibiotics, e.g. penicillins, macrolides and lincosamides such as clindamycin. 
 
Enterococci 
Enterococci are genetically resistant to penicillinase- resistant penicillins and β-lactam 
antibiotics like cephalosporins, but are mostly sensitive to ampicillin. They are also 
showing increased resistance to aminoglycosides and vancomycin, probably due to 
chromosomal genes transferred between bacteria (53).  
 
Enterobacteriaceae 
These Gram-negative bacteria are mostly sensitive to relevant antibiotics such as 
aminoglycosides, quinolones and carbapenems. There seems to be an increase in 
resistance to cephalosporins, mostly due to increased occurrence of extended spectrum 
β-lactamase (ESBL) variants (54). There are also reports of increased resistance to 
quinolones and carbapenems in Europe (55), but carbapenem resistance is still 




1.5 Treatment of infection after THA 
PJI treatment depends on the severity of the infection and ranges from soft tissue 
debridement (debridement, antibiotics and implant retention (DAIR)) in early 
postoperative infections to extensive revisions in several stages in patients with severe, 
deep infections with “difficult-to-treat” (DTT) bacteria. The choice of treatment is 
based on the type of infection, type of bacteria, time since prior surgery, anatomy and 
the extent of patient comorbidity (Figure 3) (8, 56).  






































Figure 3: Simplified flow chart illustrating treatment selection in THA PJI (56) 
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1.5.1 Soft tissue debridement 
More recently this choice of treatment has been described as “debridement, antibiotics 
and implant retention” (DAIR). In the case of acute PJI with duration of symptoms <3 
weeks in patients with viable soft tissue and relatively sensitive microbes, good results 
have been shown for DAIR treatment (57-60). Extensive debridement of the soft tissue 
is performed by removal of necrotic soft tissue, debris, and excision of sinus tracts, 
followed by a thorough irrigation of the wound before closure. In cases with a modular 
prosthesis, removable parts are exchanged. Historically this type of surgery has been 
withheld for acute postoperative infections. Due to good results, the indication span 
has by many been extended to three months and even longer after primary surgery, if 
the implant is well fixated. The outcomes of such an approach have not been studied 
in detail. DAIR treatment in Norway generally involves 12 weeks of postoperative 
antibiotic treatment. 
 
1.5.2 One-stage revision 
In cases of later/chronic PJI in patients with viable soft tissue and sensitive microbes, 
a one-stage revision with a complete removal of the prosthesis, soft tissue debridement 
and reimplantation can be performed in one surgery with relatively good results (61-
63). The advantages of one-stage revision over two-stage revision are earlier 
mobilization of patients and improved functional outcome. It also leads to reduced 
trauma due to only one, although slightly more extensive, surgery and subsequently 
reduced costs. One-stage revision in Norway is usually followed by 12 weeks of 
antibiotic treatment. 
 
1.5.3 Two-stage revision 
In acute or chronic PJI in patients with compromised soft and/or bone tissue or a loose 
prosthesis, traditional treatment has been a two-stage revision with initial removal of 
the prosthesis, followed by an interval of intravenous antibiotics. In the first surgical 
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stage, a cement spacer containing antibiotics may be implanted to secure the soft tissue 
and stabilize the joint, and to provide dead space management through elution of high 
doses of local antibiotics. Figure 4 illustrates a cement spacer containing a steel rod. 
Reimplantation is performed at a later stage when the infection is cured and the soft 
tissue is restored.  
With sensitive bacteria, the antibiotics/spacer interval can be reduced to 2-3 weeks. 
With DTT microbes the interval should be 6-8 weeks. A long antibiotics/spacer interval 
should also be implemented in cases of chronic PJI in patients with several prior 
revisions with compromised soft or bone tissue with unknown or resistant bacteria. The 
antibiotic treatment may be followed by an antimicrobial-free interval of 
approximately two weeks before reimplantation. As with one-stage revisions, a total of 
12 weeks of antibiotic treatment is usually administered. In general, good results are 
also achieved with two-stage revisions (63-66). 
 
 





1.5.4 Suppression treatment/resection arthroplasty 
If the treatment is unsuccessful, the patient does not approve of further surgery and/or 
revision is associated with great risk to patient health and safety, lifelong suppression 
treatment with antibiotics may be an option if the microbes are known and susceptible 
to relevant antibiotics (67). If the patient approves and is expected to tolerate surgery, 
a resection arthroplasty (Girdlestone procedure) might be performed. This involves 
extraction of all prosthetic components and thorough debridement of the periprosthetic 










1.5.5 Antibiotic treatment 
Antibiotic treatment is only curative when used as a supplement to surgical treatment. 
All antibiotic treatment should be long-term with a total treatment duration from 6 to 
12 weeks after revision surgery. The total duration of the antibiotic treatment is 
disputed, as recent studies have questioned the additional effect of treatment beyond 6-
8 weeks (68, 69). The most common procedure until recently has been the 
administration of intravenous antibiotics for two weeks, followed by six weeks or more 
of oral treatment. A recent trial, however, found that appropriately selected oral 
antibiotic therapy was just as effective as intravenous therapy when used during the 
first six weeks in the management of “complex bone and joint infection” (70). This has 
led to a shortening of the intravenous period in Norway, although national guidelines 
are yet to be updated. The choice of antibiotics is based on the bacteriology and 
associated susceptibility panels.  
 
Empirical treatment 
Infections with an acute and critical presentation might require initiation of antibiotic 
treatment for a life-threatening indication. Such empirical treatment without 
knowledge of the causative microbe should cover the most probable microbes. This 
requires knowledge of the suspected bacteriology. Cloxacillin is the drug of choice in 
Norway, with addition of vancomycin in cases of low- grade, chronic infection, until 
bacterial cultures are ready. If Gram-negative microbes are suspected as in cases with 
intravenous drug abuse, immunosuppression or in elderly patients with substantial 
comorbidity, empirical treatment with cefuroxime or cefotaxime is recommended (71). 
 
Bacteria-specific treatment 
This section mainly serves to give an overview of the most common types of antibiotics 
used to treat THA infections in Norway. The recommendations in this section are 
30 
  
conditional, and should be adjusted on the basis of resistance patterns, type of surgical 
approach and clinical response (71).  
 
Staphylococci 
The most common causative bacteria in Norway have been found to be methicillin-
sensitive S. aureus and S. epidermidis. The recommended treatment for these infections 
is intravenous cloxacillin for 1-2 weeks after revision surgery. The proportion of 
methicillin-resistant CoNS is shown to be increasing (72), and if methicillin resistance 
is suspected or proven, cloxacillin should be substituted by vancomycin. Intravenous 
treatment is followed by a combination of oral rifampicin and ciprofloxacin for a total 
treatment of three months. Rifampicin is added as a biofilm-active supplement to 
increase biofilm penetration (60, 73, 74), even though the true additional effect of 
rifampicin is disputed (75). In case of resistance to or intolerance of ciprofloxacin, it 
might be substituted with clindamycin, co-trimoxazole, fusidic acid, linezolid or other 
antibiotics, depending on the pattern of resistance.  
Streptococci 
The majority of streptococci are known to be susceptible to most relevant antibiotics. 
The recommendation in Norway is intravenous benzylpenicillin for two weeks if the 
clinical response is good, followed by oral phenoxymethylpenicillin or ampicillin, 
giving a total treatment duration of 6-12 weeks. 
Enterococci 
Most enterococci are susceptible to ampicillin. This is the main choice, administered 
intravenously for 4-6 weeks due to the high rate of treatment failure (76). Intravenous 




Most enterobacteriaceae in Norway are susceptible to aminoglycosides, 
cephalosporins and quinolones. The recommended treatment is intravenous 
cefuroxime or cefotaxime for two weeks, followed by oral ciprofloxacin for 4-6 
weeks. 
 
1.5.6 Antibiotic prophylaxis in Norway 
All patients receiving a THA in Norway today are given systemic antibiotic 
prophylaxis (77).  The effect is well documented even though the choice of antibiotics 
and the timing of administration is disputed (78-80). Until lately, cephalothin has been 
the drug of choice in Norway. The first dose is administered 30-60 minutes prior to 
surgery, followed by every 90th minute in a total of four doses.  Due to problems with 
supplies, a different first generation cephalosporin has been substituted for cephalothin 
in most hospitals in Norway. Cephazoline is administered in the same dose and in a 
total of four doses, but is administered 15-30 minutes prior to surgery with intervals of 
three hours as it has twice the half-life of cephalothin. In cases of penicillin allergy, 
clindamycin is used as a substitute, administered 30-60 minutes preoperatively, 
followed by every sixth hour in a total of four doses (71). In cemented THA it has been 
shown that antibiotic-loaded bone cement in addition to systemic antibiotic prophylaxis 
might increase prosthesis survival (81, 82). Administration of other local, antibiotic 





1.6 Risk factors and preventive measures for 
infection after THA 
Studies have implemented different definitions in their analysis of data sets with 
varying content, and have thereby identified different risk factors (23, 84-88) relevant 
to predict the risk of infection after THA. Risk factors common to the majority of 
studies are comorbidity (American Society of Anesthesiologists (ASA) class, Charlson 
comorbidity index (CCI)), obesity, diabetes, THA due to femoral fractures and 
prolonged duration of surgery. 
Risk factors for infection after THA known from the NAR and other similar 
surveillance registries are high ASA class, male sex, diabetes, THA due to necrosis of 
the femoral head or hip fracture, cemented implants without antibiotics and prolonged 
duration of surgery. Some have also identified the use of laminar airflow ventilation 
systems in the operating theatre as being a potential risk factor for postoperative 
infection (81, 89-91).  
From a hospital point of view, the patient-related risk factors are difficult to modify in 
the form of simple preventive measures related directly to the surgery, although 
optimization of diabetic control, weight loss, pausing smoking and administration of 
anticoagulants should be encouraged and planned from the outpatient clinic. However, 
some of the surgery-related risk factors can be directly addressed. Based partly on 
different studies on risk factors for infection after THA, systematic reviews and 
guidelines on preventive measures have been published (92-94). The measures are 
supported by inconclusive scientific proof, and the use of systemic antibiotic 
prophylaxis seems to be the only factor with sufficient evidence (94). Nevertheless, 
there is a wide consensus that thorough preoperative patient washing, short 
preoperative hospital stay, use of antibiotic-loaded bone cement, use of double surgical 
gloves and face masks, adequate surgical technique and gentle soft tissue handling are 
effective measures to help reduce the incidence of postoperative infection (82, 95-97). 
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Systematic measures to reduce the incidence of infections following arthroplasty were 
first introduced by Dr. Charnley in the early 1970s. Charnley and colleagues achieved 
a reduction of postoperative infection after THA from approximately seven to one 
percent (98). In his study, multiple measures were implemented including systematic 
iodine skin wash, use of surgical drapes, double disposable gloves, and suture of 
subcutaneous fat. The air in the operating room, however, was considered one of the 
major factors, and Dr. Charnley’s implementation of a “greenhouse” ventilation system 
led to an increased focus on the cleanliness of the air. Operating room ventilation turned 
out to be a hotly disputed topic in the following decades, and the last part of this thesis 
will discuss this in further detail.  
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1.7 Operating room ventilation 
One of the main functions of operating room (OR) ventilation is to offer adequate 
oxygen levels to patients and personnel, and to eliminate air pollutants from medical 
equipment, e.g. anaesthetic gas contamination. In addition, the air in the operating room 
is thought to be a possible risk factor of postoperative infection due to airborne particles 
that might serve as carriers of bacteria, often measured as colony forming units (CFUs). 
The cleanliness of the air is a debated topic in relation to infection reduction, but 
ventilation systems are now to a greater extent constructed as a prophylactic measure 
against postoperative infection.  
Two main principles are implemented to increase air cleanliness: conventional, 
turbulent, mixing ventilation (CV) and laminar airflow (LAF) ventilation, the latter 
more recently termed unidirectional airflow (UDF). CV systems use the dilution 
principle to reduce the concentration of air contamination. This is in contrast to the 
UDF systems, which implement the displacement principle and work by sending 
parallel streams of filtered air directly towards the operating field. The two different 
functional principles will be discussed in more detail in the following sections. 
The air supplied to the operating room (supply air) may be a mixture of filtered air from 
the outside (primary air) and recirculated and filtered air from the operating room 
(secondary air) (Figure 6), although most CV systems do not use recirculated air. 
Primary air is necessary to adequately withstand O2 pressure and is often supplied in 
quantities of 1000-2000m3/h to fulfil the requirement of at least 50m3/h of fresh air per 
person under physically demanding work (99). The total volume flow rate (VFR) of 
supply air is important to achieve an adequate reduction of contamination for both CV 
and UDF systems. Modern ventilation systems today often have a VFR of 10,000m3/h 
or more. This is to achieve adequate air velocities in UDF systems with large 














Figure 6: Simplified presentation of the operating room ventilation circuit 
The primary air is often treated in an air receiving unit containing a louver and a pre-
filter. The air is then passed through an air handling unit which contains the first filter 
stage, a temperature regulator, a humidity regulator (not required in Norway), and the 
second filter stage. Before the air is supplied to the operating room, it is passed through 
a supply air unit where it is filtered through high- efficiency particulate air (HEPA) 
filters before it enters the room through the supply air diffuser/canopy. The air in some 
systems, primarily UDF systems, is then extracted from the OR through a recycling 
unit with yet another filter stage before some of the air is sent out as exhaust air, and 
some of it is returned to the supply air unit as secondary air (Figure 6). The way the 
primary air and secondary air are processed may vary between different systems in 
regards to the degree of heat recovery as well as whether the processing is centralized 
or separated, but the details of this will not be discussed further in this thesis. 
1.7.1 Conventional ventilation 
Conventional ventilation (CV) is also known as turbulent ventilation, mixing 
ventilation, diluting ventilation or a combination of these. This reflects the functional 
principle which is to dilute the polluted air using turbulent, mixing airflows of clean 
and filtered air. The supply air is discharged from the supply unit in different directions, 
creating a turbulent airflow to mix the polluted air with clean air, thereby diluting the 
pollutants present. An important parameter of airborne particle removal in CV systems 
is the air exchange rate/air changes per hour (ACH), usually in the range of 12-25, and 
also to what degree dilution actually takes place (100). This depends on the geometry 
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of the OR as the diluting effect is not uniformly distributed throughout the room. As 
the degree of protection also partly depends on overpressure, this adds vulnerability to 
the CV systems in terms of door openings and sudden episodes of pollution (101). 
1.7.2 Unidirectional ventilation (UDF) 
LAF/UDF systems work by supplying linear and parallel streams of air with constant 
velocity directly towards the operating field. This is supposed to create a column or 
plug of fresh air displacing polluted air away from the surgical field (plug flow) (Figure 
7a). True laminar airflow can only be created in optimal surroundings, and no system 
is able to do this consistently under real-life conditions (102-104). Lately the term UDF 
has been implemented to more realistically describe the functionality, and UDF will be 
the preferred term throughout this thesis. Technological developments have been 
substantial in recent decades, mainly in regard to increased canopy size and increased 
VFR to achieve increased air velocities in large protected areas. Studies have shown 
the impact of canopy size on the microbial load within the protective zone, and the 
minimum size of an UDF canopy has been recommended to be 320 x 320 cm (105-
107). There are numerous variations of these systems with regard to airflow distribution 
configuration. Figure 7(a-d) shows the most commonly used systems in Norwegian 
hospitals.  
An important parameter for UDF systems is “recovery time” (108). Recovery time 
defines the ability of the system to reduce the concentration of air pollutants in a 
defined range of time in a defined area of the operating room. This describes the time 
it takes for the system to achieve “steady state” in the protected area after an episode 
of air pollution. Recovery time is theoretically lower in UDF systems than in CV 
systems, meaning that the effect of door openings, sudden movements, etc. could be 
less pronounced in UDF systems, at least in the protected zone (99).  
 
 
Figure 7a: Standard vertical UDF without side walls surrounding the canopy 
 





Figure 7c: Horizontal UDF 
 




There is an ever evolving development of new UDF system variations. Systems with 
local and transportable UDF diffusers have been tested out in small cohorts, but have 
not been implemented as standard, as their vulnerability to wrong implementation and 
subsequent adverse effects is a potential hazard (109, 110). A new concept involving 
undercooling of the central part of the plug flow has shown few but promising results 
in reducing the concentration of CFUs (111). A detailed presentation of new, 
experimental ventilation systems will not be provided, being beyond the scope of this 
thesis. In the following, the main focus will be on the prophylactic effect of the main 
categories of existing and well established ventilation systems in Norway. 
 
1.7.3 Ventilation as infection prophylaxis 
In the 1950s, Dr. John Charnley revealed an infection rate of around seven percent after 
arthroplasty in a conventionally ventilated operating theatre. As mentioned in Section 
1.6, he implemented numerous measures to reduce the incidence of postoperative 
infection during the 1960s. This led to a reduction of the infection rate from seven to 
almost one percent. One of these measures was the implementation of an ultraclean air 
(UCA) system to reduce the concentration of air pollutants. The first prototype system 
was known as the “greenhouse” system (112). This involved a separate enclosure 
within the OR where filtered air was introduced through the ceiling and extracted 
through slits along the floor of the enclosure (Figure 8). Air from the rest of the OR 
was thus separated from the surgical field, and exhaled air from the surgeons was 
extracted by the use of respiratory masks. Together with Harry Graven and Hugh 
Howorth, Dr. Charnley further developed the system with ever increasing VFR. The 
results were good regarding the cleanliness of the air (98), but the restriction of 
movement due to the enclosure was a matter of concern. In the 1970s, the system was 
further developed by Howorth into what must be considered the predecessor of UDF 
systems as we know them today. The supply air unit was installed in the roof of the OR 
and the canopy was encircled by partial walls as illustrated in Figure 7b. Dr. W. Whyte 




Figure 8: Sir John Charnley’s “greenhouse”. 
The results were good and due to increased freedom of movement, these systems set 
the standard for the development towards the UDF systems as we know them today. 
The prophylactic goal of the OR ventilation systems is to reduce the concentration of 
bacteria in the air. The size of the bacteria is less than 1µm but they rarely exist as free 
planktonic bacteria in the air. Most microbes in the air of ORs exists in small colonies 
on skin flakes in the size range of 4-20µm (114). These bacteria-carrying particles are 
filtered out in the air handling and supply air units of the ventilation systems where 
HEPA filters remove particles larger than 0.3 µm. The supply air is thus more or less 
particle-free, and the main source of CFUs in the OR is assumed to be people present 
(114-117). Without going into detail on this issue, it is worth mentioning four main 
mechanisms by which airborne bacteria may impact the surgical site by direct 
contamination: gravitational forces, electrostatic forces, Van der Waal forces or by 
inert impact. Gravitational forces dominate as the causative mechanism of colonization 
of operating wounds (118). Indirect contamination might also occur via surgical gloves, 
the patient’s skin or surgical instruments, the latter potentially contaminated to a greater 
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degree via electrostatic forces (119, 120). Figure 9 shows potential routes of 
contamination focusing on the air as the source of bacterial pollution.  
Air in the Operating Room (OR)
Adjacent areas












Contamination from the air in the OR Contamination to the air in the OR
 
Figure 9: Mechanisms for contamination of the surgical wound (modified with 
approval from Dr. Traversari) (99) 
 
The importance of air cleanliness in the reduction of postoperative infection has 
nevertheless been debated. Studies have shown that UDF systems are superior in 
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reducing CFUs in the air and in the proximity of the surgical field (111, 121-125). The 
main reference in recommendations of UDF systems has been a clinical randomized 
controlled trial conducted by Dr. Lidwell and colleagues in the 1970s and 1980s (126). 
The results have been debated due to some methodological issues and the fact that the 
assessment of the true effect of air cleanliness is hard to isolate (127). In summary, 
Lidwell concluded that ventilation systems which were able to maintain a CFU 
concentration below 10 per m3 reduced the incidence of “deep joint sepsis” by roughly 
50%. This has been supported by other studies showing a relation between the 
concentration of CFUs and the incidence of SSI (98, 128-130).  
Recent observational studies, however, show that UDF systems might actually increase 
the risk of SSI and revision due to infection (91, 131-133). A suggested mechanism 
behind this increase has been that the increased air velocity might lead to patient 
hypothermia and bacterial impingement, predisposing for infection. Increased 
turbulence in fringe areas and areas around the surgeon, surgical lamps, etc. has also 
been proposed as possible negative mechanisms. The quality and validity of these 
results have also been disputed due to several methodological weaknesses (134, 135); 
this will be discussed in further detail in Section 5.4, where all aspects of the true effect 








The study of the literature in this thesis was completed in February 2020.  
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2 Project aims 
2.1 General aims  
The overall aim of the project was to survey the bacteriology and antibiotic resistance 
patterns of microbes causing revision due to infection after THA in Norway, and to 
assess whether there was any correlation between bacterial findings and 
haematological infection parameters. As our microbiological findings substantiated the 
likelihood that contamination during primary surgery might lead to clinical infection 
several years later, and as the cleanliness of the air in the operating room is a possible 
risk factor of postoperative infection, we also wanted to validate the type of ventilation 
reported to the Norwegian Arthroplasty Register and to assess whether these corrected 
ventilation data affected the risk of revision due to infection after THA with several 
years of follow-up.  
 
2.2 Specific aims  
Paper I:  
To survey the bacteriology and haematological infection parameters in cases of 
revision due to infection after THA in Norway. 
Paper II: 
To survey antibiotic resistance patterns and their evolution in bacteria causing revision 
due to infection after THA in Norway.  
Paper III: 
To validate data on ventilation systems in the Norwegian Arthroplasty Register. 
To correct and supplement ventilation data in the Norwegian Arthroplasty Register 





To evaluate the true effect of different types and sub- classifications of ventilation 
systems on the risk of revision due to infection after THA in Norway. 
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3 Material and methods 
3.1 The Norwegian Arthroplasty Register (NAR)  
The Norwegian Arthroplasty Register was established in Bergen in 1987 and has since 
then registered data on THA and THA revisions. The registration form is filled in by 
the surgeon immediately after surgery and contains information on patient identity and 
characteristics, indication for surgery and several other patient- and surgery-related 
variables, including information on the type of ventilation in the operating room 
(Appendix 1). Revision is defined as removal or exchange of the whole or parts of the 
prosthesis, and revision cause (e.g. infection) is also determined immediately after 
surgery based on perioperative evaluations. Since 2011, all reoperations, including 
DAIR procedures without removal or exchange of parts, are to be reported. The 
patients’ identity number is used to link subsequent revision to the primary THA.     
 
3.2 Data collection and supplementing the NAR data 
In Papers I and II we identified the ten hospitals with the highest number of reported 
revisions due to infection in the period 1993-2007. We used the NAR to identify the 
date of revision due to infection, and each hospital was visited by the main author (HL), 
who studied the hospital notes and electronic health records for all these patients. The 
date and type of surgery were verified and peroperative bacteriological test results 
including antibiotic resistance patterns as well as preoperative haematological infection 
parameters related to the revision were collected. The data from the revision were then 
linked to the primary surgery through the patients’ personal identity number. The 
laterality of the THA (right/left) was also noted in order to eliminate errors in patients 
with bilateral arthroplasty. 
In Papers III and IV we used the NAR to identify first revisions due to infection and 
the type of ventilation reported by the surgeon from the primary surgery, i.e. CV, LAF 
or greenhouse ventilation, being the three alternatives on the register form (Appendix 
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I). To validate the information reported by the surgeon, all present and historical 
ventilation systems in the period 1987-2015 in the 40 selected hospitals in Norway 
were evaluated in cooperation with the hospital’s head engineer, the register contact 
person (a surgeon) and/or personnel from the department of infection prevention. Six 
of the hospitals were visited in order to gain knowledge of the different ventilation 
systems. The actual ventilation conditions were identified by using a detailed 
questionnaire as guidance in the direct correspondence (Appendix II). The 
questionnaire included questions on the period of use of each individual OR ventilation 
system, physical measurements like the floor area and roof height of each OR, details 
such as air velocity, type of surgical lamps and types of filters, and questions on 
different aspects of maintenance. This information was linked to each hospital in the 
NAR based on year of primary surgery and the hospital’s unique register number. In 
Paper III the existing ventilation data in the NAR were compared to the new validated 
data. In Paper IV we assessed the effect of validated OR ventilation on the risk of 
revision due to infection. 
 
3.3 Statistics 
The endpoint of all papers in this thesis is revision due to deep infection after THA 
with removal or exchange of prosthesis parts as reported to the NAR (Appendix 2). In 
Paper I we used Pearson’s chi squared test for linear trend to compare time periods and 
bacterial groups. In Paper II we used the same method to compare the prevalence of 
antibiotic resistance between time periods.  
In Paper III we compared the reported OR ventilation data with the new validated data. 
On the basis of the sensitivity, specificity and positive and negative predictive values 
of the reporting, we calculated the misreporting rate as a measure of the preciseness of 
the data reported by the surgeon. 
In Paper IV patients were followed until revision due to infection, emigration, death or 
the end of follow-up. We used simple, descriptive statistics in the presentation of 
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patient and surgery characteristics. To estimate the relationship between revisions due 
to infection after THA and OR ventilation in the period 2005-2015, we used a 
multivariate Cox regression model to calculate relative risks with 95% confidence 
intervals. P-values below 0.05 were considered significant. Adjusted survival rates and 
Kaplan-Meier survival rates were also calculated. Cumulative survival curves were 
constructed with OR ventilation system as strata.  
Analyses were conducted using SPSS version 22 (Papers I and II) and version 24 
(Papers III and IV). Supplementary analyses were conducted with R (R Foundation for 
Statistical Computing, 2014) (Papers III and IV). 
 
3.5 Ethics and conflicts of interest 
The data registration and assessment were performed confidentially based on patient 
consent and according to Norwegian and EU data protection rules. In Papers I and II 
we applied for an extension of the existing approval in the NAR from the Regional 
Ethics Committee (REK number 2009/856b). The studies were fully financed by the 
NAR and the orthopaedic departments of Haukeland and St. Olav’s university 






4 Summary of Papers I-IV 
Paper I 
Bacterial and hematological findings in infected total hip arthroplasties in Norway 
Aim: To assess the bacterial findings in infected total hip arthroplasties (THAs) in 
Norway. We also wanted to investigate the relationship between causal bacteria and 
haematological findings. 
Material and methods: Revisions reported to the Norwegian Arthroplasty Register 
(NAR) due to infection after total hip arthroplasty from 1993 to September 2007 were 
identified. One single observer visited ten representative hospitals where clinical 
history, preoperative blood samples and the bacterial findings of intraoperative samples 
were collected. Bacterial growth in two or more samples was found in 278 revisions, 
and thus included.  
Results: The following bacteria were identified: Coagulase negative staphylococci 
(CoNS) (41%), Staphylococcus aureus (S. aureus) (19%), streptococci (11%), 
polymicrobial infections (10%), enterococci (9%), Gram-negative bacteria (6%) and 
others (4%). CoNS were the most common bacteria throughout the period but in the 
acute postoperative infections (<3 weeks) S. aureus was the most frequent bacterial 
finding. We found no change in the distribution of the bacterial groups over time. S. 
aureus appears to be correlated with a higher C-reactive protein (CRP) value (mean 
140 (95% confidence interval (CI): 101-180)) than CoNS (mean 42 (CI: 31-53)). S. 
aureus also correlated with a higher erythrocyte sedimentation rate (ESR) (mean 67 
(CI: 55-79)) than CoNS (mean 47 (CI: 39-54)). 
Interpretation: In this nationwide study, based on 278 revisions of infected THA, 
staphylococci were the most common bacteria in THA revision for infection in 
Norway. S. aureus was more common in acute postoperative infections and CoNS were 
more common in early, delayed and late infections. CRP and ESR may be of help in 




Increasing resistance of coagulase-negative staphylococci in total hip arthroplasty 
infections 
 
Aim: We investigated bacterial findings from intraoperative tissue samples taken 
during revision due to infection after total hip arthroplasty (THA). The aim was to 
investigate whether the susceptibility patterns changed during the period from 1993 to 
2007.  
Material and methods: Reported revisions due to infection in the Norwegian 
Arthroplasty Register (NAR) were identified, and ten representative hospitals in 
Norway were visited. All relevant information on patients reported to the NAR for a 
revision due to infection, including bacteriological findings, was collected from the 
medical records.  
Results: A total of 278 revision surgeries with bacterial growth in more than two 
samples were identified and included. Differences between three five-year periods 
were tested for linear trend using the chi-square test. The most frequent isolates were 
coagulase-negative staphylococci (CoNS) (41%, 113/278) and Staphylococcus aureus 
(19%, 53/278). The proportion of CoNS resistant to the methicillin group increased 
from 57% (16/28) in the first period, 1993-1997, to 84% (52/62) in the last period, 
2003-2007 (P=0.003). There was also a significant increase in resistance for CoNS to 
cotrimoxazole, quinolones, clindamycin, and macrolides. All S. aureus isolates were 
sensitive to both the methicillin group and the aminoglycosides. For the other bacteria 
identified no changes in susceptibility patterns were found. 
Interpretation: We identified an increase in the proportion of PJI-causing methicillin-
resistant CoNS over the study period. Adequate bacterial sampling is crucial for 
choosing the right antibiotic treatment. This is increasingly important given the 






Operating room ventilation - Validation of reported data on 108,067 primary total 
hip arthroplasties in the Norwegian Arthroplasty Register 
Aim: To validate the information on operating room (OR) ventilation reported by 
orthopaedic surgeons to the Norwegian Arthroplasty Register (NAR). 
Material and methods: 40 of the 62 public orthopaedic units performing primary total 
hip arthroplasty (THA) in Norway from 1987 to 2015 were included.  The hospitals’ 
current and previous ventilation systems were evaluated in cooperation with the head 
engineer of the hospital. We identified the type of ventilation system reported to the 
NAR, and compared the information with the actual ventilation in the specific ORs at 
the time of primary THA.   
Results: 108,067 primary THAs were eligible for assessment.  None of the hospitals 
performed THA in true “greenhouse” ventilation. 57% of the primary THAs were 
performed in ORs with LAF and 43% in ORs with CV. Comparing the reported data 
with the validated data, LAF was reported with a sensitivity of 86.4%, specificity of 
89.4% and positive predictive value (PPV) of 91.6%, with an accuracy of 87.7%. CV 
was reported with a sensitivity of 89.0%, specificity of 86.7% and PPV of 83.5%, with 
an accuracy of 87.7%. The total mean misreporting rate was 12.3%.  
Interpretation: Surgeons were not fully aware of what kind of ventilation system they 
operated in. This study indicates that conclusions based on ventilation data in the NAR 









Operating room ventilation and the risk of revision due to infection after total hip 
arthroplasty - Assessment of validated data in the Norwegian Arthroplasty Register 
Aim: To assess the influence of validated operating room (OR) ventilation data on the 
risk of revision surgery due to deep infection after primary total hip arthroplasty (THA) 
reported to the Norwegian Arthroplasty Register (NAR). 
Material and methods: Forty orthopaedic units reporting THAs to the NAR from 
2005 to 2015 were included. The true type of ventilation system in all hospitals at the 
time of primary THA was confirmed in a previous study (136). Unidirectional airflow 
(UDF) systems were subdivided into small, low volume, unidirectional vertical flow 
(lvUDVF) systems, large, high volume, unidirectional vertical flow (hvUDVF) 
systems, and unidirectional horizontal flow (UDHF) systems. These three ventilation 
groups were compared to conventional, turbulent, mixing ventilation (CV). The 
association between the end point, time to revision due to infection, and OR ventilation 
was estimated by calculating relative risk (RR) in a multivariate Cox regression model, 
with adjustments for several patient- and surgery-related covariates. 
Results: 51,292 primary THAs were eligible for assessment. 575 of these had been 
revised due to infection. We found a similar risk of revision due to infection after THA 
performed in ORs with lvUDVF and UDHF, when compared to CV. THAs performed 
in ORs with hvUDVF had a lower risk of revision due to infection than CV (RR=0.8, 
95% CI: 0.6-0.9, p=0.01). 
Interpretation: THAs performed in ORs with hvUDVF systems had a lower risk of 
revision due to infection than those performed in ORs with CV systems. The perception 
that all UDF systems are similar and possibly harmful seems erroneous. 
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5 Main results and general discussion 
5.1 Bacteriology and serology of infected THA  
CoNS (41%) and S. aureus (19%) were the most common bacteria causing revision due 
to infection after THA in Norway from 1993 to 2007 (Paper I). Other bacteria were 
streptococci (11%), polymicrobial infection (10%), enterococci (9%), Gram-negative 
bacteria (6%) and others (4%). The bacterial spectrum concurs with results in other 
publications, although our share of S. aureus is somewhat lower (29, 30, 137-145). A 
possible explanation is that soft tissue revisions without removal or exchange of 
prosthesis parts were not reported to the NAR during the study period. Such revisions 
are often due to early THA infections caused by S. aureus, meaning that the share of S. 
aureus might be underestimated in our material (Section 5.6.2). 
Low grade, chronic infections with normal or low haematological infection parameters 
might be evaluated as aseptic loosening by the surgeon perioperatively, and might 
subsequently and erroneously be reported to the NAR as such. These low grade 
infections are probably dominated by low virulent bacteria such as CoNS and 
Cutibacterium spp., and the proportion of these might thus also be somewhat 
underestimated in our material (Sections 5.6.1 and 5.6.2). 
The distribution of the different bacterial groups remained unchanged during the 
different periods. There was a trend towards more polymicrobial infections, which in 
the majority of cases involved CoNS and Cutibacterium spp. This might be due to 
improved diagnostics and awareness of such low virulent bacteria formerly assessed as 
pollutants, during the study period (146). 
S. aureus were the most common bacteria in acute, postoperative infections and CoNS 
was the most prevalent in later infections, including infections over two years after 
primary THA. Haematological seeding of CoNS is theoretically possible, but less likely 
to occur as it has been shown to require substantial bacteraemia (147, 148). The finding 
of 40% CoNS in late infections may thus support the perception that direct 
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contamination during primary surgery is the most common route of infection after 
THA, even in infections occurring several years after primary surgery.  
Infections after THA caused by S. aureus yielded higher CRP (mean 140 (95% CI: 
101-180)) than infections caused by CoNS (mean 42 (CI: 31-53)). Combined with the 
finding of high and increasing resistance amongst CoNS to methicillin and 
aminoglycosides (Paper II), this supports a practice where vancomycin is introduced 
in cases of infected THA with low infection parameters (CRP<50) and unknown 
causative microbes in Norway. 
 
5.2 Antibiotic resistance in bacteria causing infections after THA 
There is a high and increasing resistance to antibiotics in the methicillin group amongst 
CoNS, from 57% in 1993-2007 to 84% in 2003-2007 (Paper II). This high prevalence 
of MRSE concurs with international findings (29, 30, 141, 142). CoNS also showed 
increased resistance to co-trimoxazole, quinolones, clindamycin and macrolides as well 
as a trend towards increased aminoglycoside resistance, as referred to earlier (Section 
5.1). 
There is no conclusive explanation for this general increase in antibiotic resistance. It 
has been shown that methicillin resistance among CoNS might reflect the general 
consumption of antibiotics (149, 150). The Norwegian Institute of Public Health has 
shown a generally increased use of cephalosporins and quinolones in the study period 
(1987-2007) (151), and it can be speculated that this might have contributed to the 
increase in resistance among CoNS in THA infections. Hospitalization related to 
surgery is shown to rapidly transform or displace sensitive skin colonies with more 
resistant strains (152-154), and the increase in resistance among CoNS infections after 
THA might potentially reflect an increased resistance in the nosocomial flora, which 
may be speculated to reflect the increased use of antibiotics in general practice.   
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Another possible explanation for increased resistance in bacteria causing revision due 
to infection after THA might be that the use of antibiotic-loaded bone cement with 
subinhibitory concentrations of antibiotics might lead to a selection of resistant strains 
of bacteria. In our material (Paper II) both enterococci and CoNS revealed a high share 
of aminoglycoside resistance, 90% and 59% respectively. A study from the USA found 
the share of aminoglycoside resistance among CoNS to be as low as 13% (141). In 
Norway approximately 60% of THA patients receive cemented THA (77), the vast 
majority with aminoglycoside-loaded cement, as cemented THA without antibiotics 
has been shown to increase the risk of revision due to infection compared to antibiotic-
loaded cement (81, 155). In the USA most patients receive uncemented THA and if 
cemented, bone cement without antibiotics is most commonly used (156). This might 
explain some of the differences in antibiotic resistance in these two materials. One 
study did not find increased gentamicin resistance in CoNS strains in groin colonization 
depending on whether or not bone cement was used (154); however, the authors 
emphasized that due to the small number of cases and assessment of skin colonization 
only, it was not possible to reject the hypothesis that gentamicin-loaded bone cement 
might increase the risk of THA infection with gentamicin-resistant CoNS.  
The choice of fixation method is disputed and beyond the scope of this thesis, but in 
Norway cemented THA is widely used and especially in elderly patients (>75 years) 
due to higher general survival of the prosthesis (157-159). 
We did not find any MRSA in our material. This might reflect the prophylactic 
measures implemented in Norway to reduce the spread of MRSA. Comparable 
measures have been implemented in the Netherlands with good results (160). All S. 
aureus were also sensitive to aminoglycosides, linezolid, rifampicin, co-trimoxazole 
and quinolones, which might reflect the general susceptibility of S. aureus in Norway. 
There was no major change in antibiotic resistance in the other bacteria groups during 
the study period. All streptococci were susceptible to penicillins and some very few 
strains were resistant to clindamycin and macrolides. We found no vancomycin-
resistant enterococci and all enterococci were also susceptible to linezolid. We found a 
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high proportion of aminoglycoside resistance among enterococci, but this remained 
unchanged throughout the study period. The Gram-negative bacteria were susceptible 
to aminoglycosides, but many were, as expected, resistant to ampicillin.  
 
The most common empirical treatment of severely ill patients with clinically suspected 
PJI in Norway has traditionally been a combination of cloxacillin and gentamicin. The 
latter is also the most common antibiotic in antibiotic-loaded bone cement (81). Our 
results reveal increased resistance to these antibiotics among CoNS, the most common 
bacteria in infected THA. In suspected low grade PJI in THA with unknown 
bacteriology but relatively low haematological infection parameters (CRP<50, Paper 
I), our results support the suggestion to add vancomycin as empirical parenteral 
treatment as well as a component in the cement in the case of revision.  
Results from Paper I and Paper II were included as references in the recommendations 
from the Norwegian Directorate of Health, where vancomycin is recommended in the 
empirical treatment of PJI (71). 
 
5.3 Ventilation data in the NAR  
Not all surgeons are aware of what kind of ventilation system they are operating in, and 
this resulted in a misreporting rate of 12% for both LAF and CV (Paper III). The 
recommendation in Paper III is that studies based on ventilation data from surgeons 
and surgical departments should not be interpreted without considering inaccuracies in 
the data. This includes several registry studies included in a large review published in 
the Lancet in 2016 (161), where the majority of the studies concerning THA reveal an 
increased risk of revision due to infection for THA performed in LAF compared to CV 
(91, 131, 133, 162). These studies contributed to new WHO guidelines which do not 
recommend the installation of LAF systems in new operating theatres constructed for 
ultraclean surgery (163). In Paper III we question the validity of this conclusion, based 
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on inaccuracies in the evaluated data in our material. Regarding orthopaedic surgery, 
Dr. Bischoff’s review in the Lancet also includes a prospective, non-registry study 
which shows a protective effect of LAF, but this is a study on hemiarthroplasty (164).  
 
5.4 Ventilation as a risk factor for revision due to infection after THA 
In Paper IV we use the validated ventilation data from Paper III to assess the effect of 
different ventilation systems on the risk of revision due to infection after THA. We 
found no difference between undifferentiated UDF, assessed as a whole, and CV. 
Further, we sub-classified the UDF systems based on airflow direction 
(horizontal/vertical), canopy size, and VFR. The use of large, high volume, vertical 
UDF systems (hvUDVF) was associated with a lower risk of revision due to infection 
after THA compared to CV (RR=0.8, 95% CI: 0.6-0.9, p=0.01). The other systems, i.e. 
smaller, low volume UDF systems (lvUDVF) and horizontal UDF systems (UDHF) 
showed no difference from the CV systems regarding the risk of revision due to 
infection. In Paper IV we conclude that no UDF system is harmful, and that hvUDVF 
systems should be implemented for use in ultraclean operating rooms in the future. 
The uncertain quality and validity of ventilation data has been presented as one of the 
main arguments against the results in previous registry studies. The limited follow-up 
time of the included patients has also been a matter of dispute as this has been both 
unspecified and limited to 6 to 12 months in prior studies (131, 132, 162).  In Paper I 
we found that CoNS are the most common bacteria causing revision due to infection 
after THA and the most common bacteria in late infections, occurring several years 
after primary surgery. Haematological seeding of CoNS has been shown to be a 
relatively rare event (147, 148), and this substantiates that direct contamination is the 
main route of postoperative infection, even in late infections. This gave us the incentive 
to study end point revision due to infection after THA, with four years of follow-up, as 
in the Lidwell studies (up to four years, mean 2.5 years).   
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Another factor included in our analysis is the canopy size of the different UDF systems, 
where some recommendations state a minimum size of 320cm x 320cm in order to 
safely include the patient, surgical staff and instruments within the protected area (99, 
105, 106). The canopy size is directly related to the displaced volume of air and thus 
the size of the protected field. Together with air velocity, this is considered one of the 
most important predictors of the protective effect (107). Movement of personnel in the 
UDF zone, movement of surgical lamps, etc. have been shown to reduce the cleanliness 
of the air in the operating field, mainly in the areas between the plug flow and the air 
in the rest of the OR (102, 165). A larger canopy size/UDF zone reduces the risk of 
creating turbulence in these fringe areas. All surgical activity should therefore be 
conducted within the zone and the zone should be clearly marked on the floor.  
The potential adverse effect of UDF systems has been speculated to be caused by 
bacteria being impinged in the surgical wound due to high air velocities, also 
speculated to cause local hypothermia due to disruption of the protective thermal plume 
of the wound (117, 131, 166, 167). Some have also shown that UDF might lead to 
general hypothermia, a known risk factor for infection (168). To counteract the 
hypothermic effect, many have implemented the use of “forced air warming” (FAW) 
(Bair Hugger system, etc.), which is again thought to disrupt the unidirectional airflow 
(169, 170). These findings are disputed, and the evidence is sparse (171-173). It has 
recently been shown that a sufficient air velocity at a level of 0.35 m/s of the 
unidirectional airflow counteracts the negative effect of the thermal plume of the FAW 
(174, 175). To achieve such air velocities and at the same time maintain a large enough 
protected area with the use of large area canopies, the UDF systems should have a 
sufficient VFR in the magnitude of > 10,000 m3/h. In Paper IV we show that hvUDVF 
systems with canopy size >10 m2 and VFR >10,000 m3/h are associated with a lower 
risk of revision due to infection after THA than CV systems, while the lvUDVF 
systems did not show the same effect. These are comparisons in a rough format, but 
they clearly emphasize the importance of ventilation system differentiation based on a 




In Paper III we show that many surgeons do not know what kind of ventilation system 
they are operating in. Maximal effect of UDF systems requires correct implementation, 
which may be speculated to be a weakness of these systems (176). If one is unfamiliar 
with one’s own kind of ventilation system, it is difficult to use it in a correct matter. 
Discipline in the operating room has been shown to affect air cleanliness where the 
number of personnel in the room, activity level and the number of door openings are 
considered important variables (176-178). This applies to both UDF and CV systems, 
where UDF systems are known to have a lower recovery time and might deal with 
sudden emissions of pollutants more rapidly. This does not, however, imply that one 
can behave at will and that UDF can defuse any unwanted episode of pollutant emission 
(178, 179). A sense of false security might lead to inappropriate behaviour, which 
might nullify the protective effect of UDF systems. Knowledge of the ventilation 
conditions and correct use of the different systems may thus be essential in the 
operating room of the future. This is discussed in an annotation by Dr. Thomas in the 
Bone and Joint Journal, where correct implementation is emphasized as an important 
factor (135). Even without knowledge of the use and implementation of the different 
systems in our material, our findings in Paper IV still indirectly support this, as 
incorrect use and implementation would in theory and most likely have negatively 
affected our results regarding UDF systems. Despite this, we show that hvUDVF 
systems perform better than the other systems as a prophylactic measure against PJI. 
Trends in operating room ventilation have gone through different phases. UDF systems 
entered the ORs after Lidwell’s Medical Research Council (MRC) study, which found 
a relative risk of 0.4 when comparing ultraclean systems with non-ultraclean systems 
in arthroplasty surgery. The study has been disputed due to some methodological 
weaknesses, where the main arguments have been as follows: it is a randomized study 
on 19 hospitals in four countries, the authors do not thoroughly adjust for the use of 
systemic antibiotic prophylaxis, the randomization practice varies between the 
hospitals, one type of ventilation system (Allander systems) was transferred from the 
ultraclean group to the non-ultraclean group during the study period due to some 
unsatisfactory measurements, CFUs were measured by different means and without 
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standardized intervals, Cox regression was not used to account for varying follow-up 
time and disappearance, and one of the hospitals accounted for 1/3 of the infections in 
both the ultraclean and control group. Because of this and conflicting results in studies 
from national surveillance registries, the new WHO guidelines in 2016 made a 
conditional recommendation that UDF systems should not be installed in future 
operating rooms in order to reduce the incidence of postoperative infection after 
arthroplasty (163). But the wind is about to change again. One of Lidwell’s companions 
and co-authors, Dr. Whyte, has with others reevaluated the findings in the original 
MRC paper (134). They emphasize the importance of evaluating the degree of 
contaminant removal of the ventilation systems, rather than the schematic 
configuration, and they present in detail why the results from the MRC study should 
still be considered valid, which implies that the use of UDF systems should be 
encouraged. Although we did not include measurements of contaminant reduction of 
the various ventilation systems, the findings in our material seem to support this wind 
of change. 
Despite this, there is a series of arguments implying that air cleanliness is not a 
dominating risk factor for postoperative infection. As mentioned, in the MRC study 
one hospital reported 1/3 of the infections in both the ultraclean group and the control 
group. This alone questions the importance of air cleanliness compared to other risk 
factors. Further, studies on the bacteriology of infected shoulder arthroplasty and 
infected spinal implants show a different bacteriological spectrum than in infected 
THA (39, 180, 181), with a high proportion of Cutibacterium acnes, a species known 
to be abundant in sebaceous glands in the follicles of the skin in such regions, thus 
indicating that the patient is the source of infection. This is supported by differences in 
infection rates between sexes, where men have twice the risk of revision due to 
infection after THA compared to women, as shown in Paper IV, and gene studies 
showing that SSI after elective orthopaedic surgery is more frequently caused by 
endogenous transmission than previously assumed (182). Two recent Swedish studies 
using multilocus sequence typing following PCR amplification when studying S. 
epidermidis in PJI show that the air in the operating room does contain substantial 
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amounts of CoNS, but does not seem to contain the sequence types of S. epidermidis 
strains most likely to cause PJI (183, 184).  
Nevertheless, UDF systems create cleaner air with regards to both particle and 
microbial load, and the contribution of airborne bacteria in postoperative infection 
cannot be ruled out (111, 121-125). Our studies on OR ventilation involve a scenario 
in which all patients received an effective antibiotic prophylaxis. In spite of this, we 
show a protective effect of the hvUDVF systems in validated surveillance data. 
Without any antibiotic effect, the situation would probably have been different, and the 
importance of air cleanliness might have been more substantial. In such a scenario, 
which is in fact not unlikely to occur (185), one must reduce the impact of all risk 
factors to a minimum in order to avoid postoperative infection. This includes the 
cleanliness of the air and correct implementation and use of UDF systems, which will 
be important in the operating room of the future.    
 
5.5 Methodological evaluations and limitations 
Revision due to infection after THA is a relatively rare phenomenon with an incidence 
of 1.1% in our material. To study such a rare end point requires large amounts of data 
of a magnitude that can only be assessed in practice by using national surveillance 
databases. The data in the NAR have been shown to be of good completeness for both 
primary and revision surgery (186, 187). But large data registers have some inherent 
challenges that will be discussed in the following.  
 
5.5.1 Confounding 
Large register studies will be affected by residual confounding as the number of 
adjustment variables in the analyses will be limited. Papers I, II and III were not 
directly affected by statistical confounding, since we examined the bacteriology and 
the quality of reporting, and did not conduct large, multivariate analyses with numerous 
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adjustment variables. However, the diagnostics have changed somewhat over time and 
this might have led to time-dependent confounding in Papers I and II. Increased 
awareness of low grade infections and diagnostics targeted at e.g. CoNS and 
Cutibacterium spp. in the later years of the study period might have led to an 
underestimation of such low virulent bacteria early in the study period due to 
insufficient identification methods. This is in addition to possible clinical 
underestimation of low grade infection with subsequent misreporting of such as aseptic 
loosening.  
In Paper IV, we could only suggest the association between OR ventilation and revision 
due to infection as several unknown confounders were probably involved, e.g. physical 
behaviour in the OR, incorrect implementation and maintenance of the systems and 
many other factors that could have affected the functionality of the systems: we had no 
information on the number of personnel in the OR, the number of door openings, type 
of clothing, use of FAW, use of surgical drapes, etc. However, we do not believe that 
these factors have led to systematic errors. THA was chosen as the surgical reference 
as it is relatively standardized surgery, and as variations between hospitals regarding 
perioperative management of patients are assumed to be small. This also applies to the 
assumption that revision due to infection is somewhat underestimated (188-190). The 
reporting rate is assumed to be evenly distributed between the hospitals throughout the 
periods involved, as it is shown to be for general completeness in the NAR (186, 187). 
We found an increased proportion of hvUDVF in recent years (Paper IV, Figure 1) and 
the use of uncemented THA is also increasing (77). These factors are parallel to an 
increased risk of revision due to infection after THA in Norway (155). Thus they are 
time-dependent confounders which we have addressed by adjusting for the year of 







Papers I and II are subject to reporting bias. In Paper I we found that the bacteriology 
depended on the time passed since primary surgery. Only revisions with removal or 
exchange of prosthetic parts were reported to the register in the study period, and soft 
tissue debridement with retention of the prosthesis was therefore not included. Such 
infections are often early infections caused by S. aureus (Paper I), which might have 
led to an underestimation of these in our results. As some low grade infections might 
have been misreported as aseptic loosening, this might also have led to an 
underestimation of CoNS in our material, as pointed out earlier.  
Modular THAs (Figure 2) contain removable parts which are exchanged during a 
DAIR procedure. Such revisions have thus been reported to the NAR throughout the 
study period of Paper IV. Monoblock THAs do not contain removable parts, and DAIR 
procedures for such prostheses were therefore not reported to the NAR until 2011, since 
when all THA reoperations were to be reported, regardless of whether prosthetic parts 
were removed/exchanged or not. This may have led to an underreporting of revision 
due to infection after monoblock THA. This reporting bias was addressed by adjusting 
for modularity.  
In Papers III and IV, 40 hospitals reporting 66% of the primary THAs to the NAR were 
included for validation of ventilation data. Both the included hospitals and the 22 
excluded hospitals had THA activity throughout most of the period and similar 
distribution between rural hospitals, regional/university hospitals and specialized 
elective hospitals. The hospitals in the two groups also had similar completeness of 
reporting of both OR ventilation and primary THA (77, 186). Thus, we believe that the 
impact of selection bias was minor. 
In Paper IV, only two hospitals reported the use of UDHF. In addition, these two 
hospitals had a higher proportion of uncemented THA. This adds selection bias to these 
results, also assessed by adjusting for method of fixation. In general, we nevertheless 
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believe that the high grade of completeness in the NAR results in a relatively low 
impact of selection bias.  
 
5.5.3 Internal and external validity 
With high completeness and coverage of the data in the NAR (77), we believe that the 
results in Papers I-IV are all of high internal validity. Bacteriology and antibiotic 
resistance patterns might vary with regards to population geodemography, thus perhaps 
limiting the direct external validity of Papers I and II. Indirectly, however, it is 
important to show that efforts in Norway to inhibit the development of antibiotic 
resistance and the spread of resistant bacteria have probably contributed to a low 
occurrence of e.g. MRSA in the Norwegian bacterial flora. 
Papers III and IV must be considered of high external validity, as this is the first register 
study using validated ventilation data to assess technical sub-classifications of UDF 
systems with several years of follow-up. This is emphasized by the fact that existing 




CoNS is the most common bacteria causing revision due to infection after THA in 
Norway, with increasing resistance to the antibiotics used in both prophylaxis and 
empirical treatment of PJI in Norway. Numerous risk factors influence the occurrence 
of PJI, and the type of ventilation system seems to be one of them. Currently, air 
cleanliness seems to be important up to a certain point beyond which other factors 
might be more influential. Nevertheless, with increasing antibiotic resistance amongst 
common causative bacteria, it is necessary to reckon with a reduced antibiotic effect in 
the future. All possible efforts to reduce the peroperative bacterial load to a minimum 
must therefore be implemented. This includes installation of large, high volume UDVF 
(hvUDVF) systems in ORs where ultraclean surgery is to be performed. This 













7 Future directions 
Antibiotic resistance is increasing and must be monitored in all medical disciplines 
dealing with infections. This is necessary in order to offer the best possible prophylaxis 
and treatment, and also to identify necessary measures to reduce specific challenges in 
the development of antibiotic resistance.  
Technological advances and correct implementation and use of UDF systems will be 
essential to optimize the air cleanliness of ORs in the future. The microbiological effect 
of the ventilation systems should be evaluated in a more direct manner. It is challenging 
to isolate the air cleanliness close to the surgical wound as a risk factor for 
postoperative infection. Interdisciplinary cooperation between technical personnel, 
engineers, infection prevention personnel and surgeons will be of great value in 
enhancing knowledge of the field. Better methods of monitoring CFUs during real-life 
surgery should be developed and implemented in a manner that does not conflict with 
surgical activity. Further, methods for evaluating the microenvironment of the surgical 
wound with regards to humidity, temperature, and contamination in different stages of 
surgery should be developed and used to compare real-life surgery performed with 
different technical sub-classifications of ventilation systems. This could help in 
answering various questions about where the infections arise from and to what degree 
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Abstract: Our aim was to assess the bacterial findings in infected total hip arthroplasties (THAs) in Norway. We also 
wanted to investigate the relationship between causal bacteria and hematological findings. Revisions reported to the 
Norwegian Arthroplasty Register (NAR) due to infection after total hip arthroplasty during the period 1993 through 
September 2007 were identified. One single observer visited ten representative hospitals where clinical history, 
preoperative blood samples and the bacterial findings of intraoperative samples were collected. Bacterial growth in two or 
more samples was found in 278 revisions, and thus included. The following bacteria were identified: Coagulase-negative 
staphylococci (CoNS) (41%), Staphylococcus aureus (S. aureus) (19%), streptococci (11%), polymicrobial infections 
(10%), enterococci (9%), Gram-negative bacteria (6%) and others (4%). CoNS were the most common bacteria 
throughout the period but in the acute postoperative infections (< 3 weeks) S. aureus was the most frequent bacterial 
finding. We found no change in the distribution of the bacterial groups over time. S. aureus appears correlated with a 
higher C-reactive protein value (CRP) (mean 140 (95% Confidence interval (CI): 101-180)) than CoNS (mean 42 (CI: 31-
53)). S. aureus also correlated with a higher erythrocyte sedimentation rate value (ESR) (mean 67 (CI: 55-79)) than CoNS 
(mean 47 (CI: 39-54)). 
Keywords: Bacteriology, CRP, hematological findings, intraoperative bacterial samples, prosthetic joint infection, revision due 
to infection, staphylococci, total hip arthroplasty. 
INTRODUCTION 
 Approximately 7,000 primary total hip arthroplasties 
(THA) are performed annually in Norwegian hospitals [1]. 
Infection after primary THA is a relatively rare event, and 
large numbers of patients are therefore needed to assess 
bacteriology and trends. In recent years there have been 
indications of an increasing risk for revision due to infection 
after THA [2-4], and the question has been raised as to 
whether this might be due to changes in bacteriology [5]. 
The bacteria most frequently causing prosthetic joint 
infections (PJI) are staphylococci (i.e. Coagulase negative 
staphylococci (CoNS) and Staphylococcus aureus (S. 
aureus)), and biofilm formation and emerging resistance 
towards antibiotics represent a challenge in PJI treatment [6-
8]. However, many different bacterial species may cause 
PJIs and there has previously been no nationwide assessment 
of bacteria causing revisions of THAs in Norway.  
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Identification and diagnostics of PJI may be challenging, and 
in addition to bacterial samples, C-reactive protein (CRP) 
and erythrocyte sedimentation rate (ESR) are important 
hematological markers in diagnostics [9]. 
 Our aim was to investigate the bacterial findings in 
infected THAs in Norway by using the nationwide 
Norwegian Arthroplasty Register (NAR) to identify cases of 
revision due to infection, and then collect additional 
information on bacterial and hematological findings. We also 
wanted to assess whether CRP and ESR correlated with 
bacterial findings, and whether there were any time trends 
regarding the bacterial findings. 
MATERIAL AND METHODS 
 The NAR has since its inception in 1987 registered data 
on both primary THAs and THA revisions in Norway [10], 
and the NAR data has been validated as being of good 
quality [11, 12]. The register form is filled in by the surgeon 
immediately after surgery, containing information on reason 
for surgery and different patient and surgery related 
variables. A unique identification number of the patient is 
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used to link the primary THA surgery to later revisions. 
Since the form is filled in immediately after surgery in the 
case of a revision, the diagnosis of e.g. deep infection or 
aseptic loosening is based on clinical, biochemical and 
radiological findings pre- and intraoperatively. The cause of 
the revision is reported to the NAR before the results from 
the intraoperative bacterial samples are ready, and may not 
be corrected later. 
 From January 1993 through September 2007, 62 
hospitals reported 1,089 revisions due to infection after THA 
to the NAR. These included revisions where parts of or the 
whole prosthesis was removed or replaced due to infection. 
Also cases of re-revision that showed different bacterial 
findings to the prior revision were included. We performed a 
pilot study at three large university hospitals, before 
extending the study to include the ten hospitals with the 
highest number of reported THA revisions due to infection 
during the period. The ten hospitals were geographically 
spread throughout the whole country and had similar rates of 
revision due to infection as the national average (0.6%) [5]. 
So of all THAs performed in Norway, approximately 0.6% 
are revised due to infection and reported to the NAR. The 
hospitals were visited by the first author and information on 
bacterial findings of intraoperative samples was collected 
from the patients’ medical records. Results from 
preoperative blood samples were not collected in the three 
hospitals in the pilot study, but were added from the seven 
hospitals in the main study. Preoperative CRP and ESR 
within three days before the revision due to infection were 
assessed and compared to the bacteriological findings. 
 For the revision to be included there had to be growth of 
the same bacteria in two or more periprosthetic tissue 
samples collected intraoperatively, according to the 
definition of PJI [13]. Preoperative joint aspirations were not 
included. On average five samples were taken. None of the 
removed parts were sonicated, as this has not been procedure 
in Norway. Polymicrobial infection was defined as infection 
with more than one species (at least two of each) in 
intraoperative samples. 
 The study period was divided into three 5-year time 
periods to assess for time trends. Time from index THA to 
subsequent revision due to infection was divided into acute 
postoperative (less than 3 weeks), early (3 weeks to 3 
months), delayed (3 months to 2 years) and late infections 
(more than 2 years). 
 The ten hospitals reported 454 identifiable revisions due 
to infection to the NAR. 138 of these had no growth 
inintraoperative tissue samples and 38 of the revisions had 
growth in only one periprosthetic tissue sample and were 
therefore excluded (Fig. 1). Hence, 278 THAs reported to the 
NAR for revision due to infection and verified by bacterial 
cultures were included. Time from index THA to revision 
was addressed in only 227 of the cases, mainly due to 
missing registration of the index THA in the NAR.CRP and 
SR were addressed in 166 of the cases.  
 The patient characteristics are presented in Table 1 and 
shows that 98.4% of the patients are reported to have 
received systemic, antibiotic prophylaxis. From 2003 the 
prophylaxis has consisted mainly of Cephalotin according to  
 
national guidelines. This is supported by a study from the 
NAR also showing a reduction in the use of β-lactamase 
resistant penicillin as prophylaxis after 1996 [14]. 
 
 
Fig. (1). Flow chart showing the patient selection. 
 
 Pearson’s chi-squared test and linear-by-linear association 
were used to compare time periods and groups of bacteria. P-
values less than 0.05 were considered significant. Statistical 
analyses were performed using SPSS version 22 (SPSS Inc., 
2004). The study was approved by the Regional Committee for 
Medical Research Ethics (number 2009/856b). 
Table 1. Patient characteristics. 
 
Sex 
 Male 32.4% 
 Female 67.6% 
Age	  
 Mean 69.4 
 SD 10.9 
Diagnosis	  
 Osteoarthritis 67.3% 
 Inflammatory  4.0% 
 Other 28.7% 
Antibiotic Prophylaxis Systemically	  
 Yes 98.4% 
 No 1.6% 
Method of Fixation	  
 Uncemented 11.1% 
 Cement	  
 With antibiotics 72.2% 
 Without antibiotics 16.7% 
Revisions from 10 included 
hospitals
Revisions with missing data
Revisions with valid laboratory 
reports
Negative cultures
 Growth in only one sample 








378    The Open Orthopaedics Journal, 2015, Volume 9 Langvatn et al. 
RESULTS 
Bacteriology of THA Infection 
 The distribution of microbes is presented in Table 2. 
Staphylococci (60%) were the most common, followed by 
streptococci (11%) and enterococci (9%). 10% of the 
infections were polymicrobial. Table 3 presents the different 
CoNS species with S. epidermidis being the most common. 
Among the polymicrobial infections, staphylococci were 
involved in all except four. The combination of CoNS and 
corynebacteria was most common. Table 4 shows the 
combinations of bacteria for polymicrobial THA infections. 





S. aureus 53 19% 
CoNS 113 41% 
Streptococci 30 11% 
Gram-negative 17 6% 
Others 12 4% 
Enterococci 26 9% 
Polymicrobial 27 10% 
 




S. epidermidis 43 
S. capitis 3 
S. lugdunensis 3 
S. warneri 1 
S. simulans 1 
Unspecified CoNS 46 
S. epidermidis and unspecified CoNS 12 
S. epidermidis, S. xylos and S. lentus 1 
S. epidermidis and S. hominis 1 
S. haemolyticus and S. capitis 1 
 
Bacterial Findings and Time After Index THA 
 Bacterial findings relative to time after index THA are 
presented in Fig. (2). The first 3 weeks all infections were 
either with Staphylococci or polymicrobial, and S. aureus 
was the most frequent bacteria. Later on the bacterial 
findings were more diverse. 
Bacterial Findings, CRP and ESR 
 S. aureus infections were associated with higher CRP 
(mean 140 (95% Confidence interval (CI): 101-180)) than 
infections caused by CoNS (mean 42 (CI: 31-53)) (Fig. 3a). 
This was also found for ESR when S. aureus infections 
(mean 67 (CI: 55-79)) were compared to CoNS infections 
(mean 47 (CI: 39-54)) (Fig. 3b). S. aureus infections were 
also associated with higher CRP than infections caused by 
enterococci (mean 43 (CI: 19-68)). 





CoNS and corynebacteria 6 
CoNS and S. aureus 4 
CoNS and Gram-negative 4 
Enterococci and Gram-negative 4 
S. aureus and streptococci 2 
S. aureus and enterococci 2 
CoNS and enterococci 1 
CoNS, S. aureus and enterococci 1 
CoNS, S. aureus and streptococci 1 
Enterococci and peptostreptococci 1 
CoNS, Gram-negative, enterococci and streptococci 1 
Time Trend of Bacterial Findings 
 The incidence of the different bacteria was mostly 
unchanged throughout the study period, but there was a trend 
towards more polymicrobial infection (p=0.1). 
DISCUSSION 
 CoNS were the most common bacteria causing revision 
due to deep infection after THA. Since CoNS are regarded as 
commensal bacteria, this may support the idea that direct 
contamination is the most common mechanism of THA 
infection [15-17]. Our bacterial findings were similar to 
those in other publications [18-28], although the share of S. 
aureus was somewhat lower than in some of the 
publications. 
 S. aureus was the most frequent bacterium in acute 
postoperative infections, whereas CoNS were the most 
common cause of revision due to infection in early, delayed 
and late infections. As late infection is most prevalent in our 
study, it may be that suppressed and biofilm embedded 
CoNS infection can emerge even after 2 years 
postoperatively, or that CoNS are spread through 
hematogenous seeding. 
 S. aureus infections had higher CRP and ESR values than 
CoNS infections. Given high resistance to methicillin and 
aminoglycosides amongst CoNS [29], in empirical treatment 
of infected THA with low CRP (<50) in Norway, 
Vancomycin should be considered until results of 
intraoperative cultures are known. 
 The incidence of the different bacteria was mostly 
unchanged throughout the study period. There was a trend 
towards more polymicrobial infection and the combination  
 





Fig. (3). (a, b) Mean values of ESR and CRP level with 95% 
confidence intervals (CI) for different species of bacteria cultured 
after revision surgery. 
of CoNS and corynebacteria was most common. This may be 
explained by better sample handling, better culturing 
methods and increased attention to pathogens formerly 
considered as contamination by commensal bacteria, not able 
to cause infection (e.g. corynebacteria). 
 The retrospective nature of this study represents one of 
the major limitations of this paper. Another weakness of our 
study is that only revisions with removal or change of the 
whole or parts of the prosthesis are reported to the NAR. 
Accordingly, soft tissue debridement of infected THAs 
without exchange of prosthesis parts is not reported to the 
register. Consequently not all surgical site infections after 
THA are reported. This may have affected the distribution of 
the bacterial findings since surgical site infection is an early 
postoperative event [30], and it may have led to an 
underestimation of e.g. S. aureus in our study. Further, low 
grade infections with low or normal CRP or ESR may be 
evaluated by the reporting surgeon as an aseptic loosening 
and hence erroneously reported to the NAR as such. These 
low grade infections, not identified in preoperative 
diagnostics, will not be included in our study, and the 
prevalence of low-virulent bacteria such as CoNS may be 
underestimated. 
CONCLUSION 
 In this nationwide study, based on 278 revisions of 
infected THA, staphylococci were the most common bacteria 
in THA revision for infection in Norway. S. aureus was 
more common in acute postoperative infections and CoNS 
were more common in early, delayed and late infections. 
CRP and ESR may be of help in differentiating between 
infections caused by CoNS and S. aureus. 
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We investigated bacterial findings from intraoperative tissue samples taken during revision due to infection after total hip
arthroplasty (THA). The aim was to investigate whether the susceptibility patterns changed during the period from 1993 through
2007. Reported revisions due to infection in the Norwegian Arthroplasty Register (NAR) were identified, and 10 representative
hospitals in Norway were visited. All relevant information on patients reported to the NAR for a revision due to infection, including
bacteriological findings, was collected from the medical records. A total of 278 revision surgeries with bacterial growth in more
than 2 samples were identified and included. Differences between three 5-year time periods were tested by the chi-square test for
linear trend. The most frequent isolates were coagulase-negative staphylococci (CoNS) (41%, 113/278) and Staphylococcus aureus
(19%, 53/278). The proportion of CoNS resistant to the methicillin-group increased from 57% (16/28) in the first period, 1993–
1997, to 84% (52/62) in the last period, 2003–2007 (P = 0.003). There was also significant increase in resistance for CoNS to
cotrimoxazole, quinolones, clindamycin, and macrolides. All S. aureus isolates were sensitive to both the methicillin-group and
the aminoglycosides. For the other bacteria identified no changes in susceptibility patterns were found.
1. Introduction
Thedevelopment of bacterial resistance has been an emerging
problem since the introduction of the first antibiotics [1].
Studies of prosthetic joint infections (PJIs) have shown a high
prevalence of methicillin-resistant Staphylococcus aureus
(MRSA), methicillin-resistant Staphylococcus epidermidis
(MRSE), extended-spectrumbeta-lactamase-resistantGram-
negative bacteria (ESBL), and other highly resistant bacteria
in PJI [2, 3].
Norway has a lower incidence of highly resistant bacteria
compared to most European countries, but in selected pop-
ulations, such as intensive care unit patients with infected
foreign bodies (e.g., central venous catheters), an increasing
proportion of infections are caused byMRSE [4, 5]. PJIs, such
as an infected total hip arthroplasty (THA), impose a burden
to the affected patients and are difficult to treat. An increased
risk of revision due to deep infection after THA has been
found inNorway as in the other Nordic countries [6, 7]. It has
been suggested that increased bacterial resistance may have
contributed to the increased risk of revision due to infection
[8].
The aim in the present study was to investigate whether
the susceptibility patterns had changed during the observa-
tion period from 1993 through 2007 for the bacteria causing
deep infection after THA in Norway.
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Figure 1: Flowchart showing the selection of patients.
2. Material and Methods
Since its inception in 1987,The Norwegian Arthroplasty Reg-
ister (NAR) has collected individual information on primary
and revision THA [9]. Based on preoperative clinical exam-
inations, laboratory tests, and intraoperative findings, the
reason for revision is reported immediately after surgery by
the surgeon to the NAR. The patients in this study were
reported as revisions for infections. Bacterial findings were
not reported to the NAR.
Patients from the period January 1, 1993, to September 30,
2007, were included. The study period was divided into three
5-year periods, which were compared to evaluate possible
changes of resistance during the study period.
Based on registrations in the NAR, the ten hospitals with
most THA-revisions due to infection, spread all over Norway,
were visited by a single observer. This reflects large volumes
of surgery, not higher rates of infection. Revision was defined
as exchange or removal of parts or the whole prosthesis.
For capacity reasons, we had to limit the number of visited
hospitals to ten.These hospitals reported half of the revisions
for infected THAs in the study period. Bacterial findings and
susceptibility charts from the medical records were collected
(Figure 1). To be included, the clinical diagnosis of infection
had to be verified by two or more intraoperative tissue










Antibiotic prophylaxis systemically (%)
Yes 98,4
No 1,6





samples with valid growth of the same bacteria. Identification
of the bacteria also had to include susceptibility panels. The
tissue samples were handled fresh; mostly five samples were
taken. There was no sonicated prosthesis included, as this
method was, and still is not, in routine use in Norway. Thus,
revisions reported as infections, but with no growth in intra-
operative tissue samples, were not included (𝑛 = 139). These
were mostly cases in which the patients had received antibi-
otics prior to surgery.
278 patients met the inclusion criteria. Patient character-
istics are described in Table 1.
In addition, awritten survey from all Norwegianmicrobi-
ology laboratories was performed, asking about their culture
techniques and growth media, incubation time, susceptibil-
ity panels, and breakpoints. In 2007, all the microbiology
laboratories followed the recommendations for susceptibility
patterns and breakpoints determining S, I, and R (SIR =
Sensitive, Intermediate, Resistant) for the different bacteria,
as recommended by the AFA (the Norwegian workgroup for
questions regarding antibiotics). However, during the study
period, the laboratories changed the susceptibility panels
from 1, 2, 3, and 4 to SIR. We transformed 1 as S, 2 and 3 as I,
and 4 as R. SIRwas dichotomized into either S or R, regarding
I as R to separate the sensitive bacteria from the rest.
The laboratories had, to some extent, used different
methods, susceptibility panels, and incubation times over the
15 years studied. The mean incubation period was 7 days in
2007.
In general, few of the cultures were tested against line-
zolid, carbapenems, and rifampicin because those antibiotics
were not part of the standard susceptibility panels used in
Norway during the study period. In addition, few staphylo-
cocci were tested against the quinolones because the Norwe-
gian regulatory authorities do not want the quinolones avail-
able in Norway (ciprofloxacin and ofloxacin) to be used rou-
tinely in the treatment of Gram-positive infections, in order
to avoid the development of resistance.
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We chose to combine methicillin, oxacillin, and cloxa-
cillin in one group called the methicillin group. The labo-
ratories used one of the above as a marker for resistance
towards cloxacillin, dicloxacillin, and all cephalosporins.
Furthermore, we combined the aminoglycosides gentamicin,
tobramycin, and netilmicin into one aminoglycoside group.
Ciprofloxacin and ofloxacin were combined in the quinolone
group. Imipenem and meropenem were combined in the
carbapenem group. Ceftazidime, ceftriaxone, and cefotaxime
were combined in the third generation cephalosporin group.
The study was approved by the Regional Committee for
Medical Research Ethics (number 2009/856b).
The chi-square test for linear trend was used to evaluate
changes over time in the distribution of resistance. 𝑃 values
less than 0.05 were considered significant. Statistical analyses
were performed using SPSS version 20 (SPSS Inc., 2004).
3. Results
The distribution of bacteria isolates is presented in Table 2.
Coagulase-negative staphylococci (CoNS) were the dominat-
ing bacteria (41%), followed by S. aureus (19%).The results for
antibiotic susceptibility are summarized in Table 3.
3.1. Coagulase-Negative Staphylococci. We found a high prop-
ortion of resistant strains among CoNS. Resistance increased
with time. All CoNS cultures retained full susceptibility only
to linezolid (only tested the last years) and vancomycin.
Resistance significantly increased over time to the methi-
cillin group (𝑃 = 0.003), clindamycin (𝑃 = 0.048), trime-
thoprim/sulfamethoxazole (cotrimoxazole) (𝑃 = 0.03),
quinolones (𝑃 = 0.03), and macrolides (𝑃 = 0.03). A trend of
increased resistance was seen for aminoglycosides (𝑃 = 0.15)
(Figure 2). Only a few rifampicin-resistant strains were iden-
tified, and only during the last 5-year period.
3.2. Staphylococcus aureus. All S. aureus cultures were susce-
ptible to aminoglycosides, the methicillin group, rifampicin,
vancomycin, linezolid, and cotrimoxazole. A few strains were
found to be resistant to fusidic acid, clindamycin, quinolones,
and macrolides.
3.3. Streptococci. All streptococci were susceptible to peni-
cillin. A few strains were found to be resistant to clindamycin
and macrolides.
3.4. Enterococci. All enterococci were susceptible to linezolid
and vancomycin, and only one was resistant to ampicillin.
However, a large proportion of the enterococci were resistant
to aminoglycosides throughout the study period. We did not
have information on whether some of the enterococci were
highly resistant, so-called high-level gentamicin-resistant
enterococci (HLGRE).
3.5. Gram-Negative Bacteria. The Gram-negative bacteria
were all but one susceptible to aminoglycosides. A few strains
were resistant to quinolones; a large proportion of the strains
were resistant to ampicillin.
Table 2: Type of bacteria.
Frequency Percent
Coagulase-negative staphylococci 113 41
Staphylococcus aureus 53 19
Streptococci 30 11
Enterococci 26 9
Gram-negative bacteria 17 6
Polymicrobial 27 10
Other microbes 12 4
Total 278 100
4. Discussion
We found a high proportion of resistant strains amongCoNS,
and we found that resistance increased with time.
Formany years, CoNSwere considered incapable of caus-
ing serious clinical infection and discarded as contamination
when found in periprosthetic tissue cultures. However, CoNS
are now considered amajor cause of PJI [8, 10].We found that
CoNS was the most frequent bacteria causing infected THA
in Norway.
The CoNS are skin commensals. When found in patients
outside hospital settings, these bacteria exhibit less antimi-
crobial resistance than bacteria isolated from hospitalized
patients and hospital personnel. Rapid transformation from
susceptible to resistant strains has been shown soon after
patients have been hospitalized [11–13]. Pre- and postopera-
tive hospitalization for primaryTHAmayhave influenced the
finding of a high proportion of multidrug resistant CoNS, as
could the extensive use of cement containing antibiotics.
We do not know if the increased proportion of resistant
CoNS is due to a general transformation of the bacterial flora,
or if it only reflects a selection of bacteria causing THA infec-
tion. Epidemiologic surveys of CoNS susceptibility are absent
in Norway.
The emergence of drug resistance in CoNS has been
shown to reflect the consumption of antibiotics [14, 15]. We
do not have data on the use of antibiotics for each individual
patient, except for prophylaxis in primary THA as reported to
theNAR.TheNorwegian Institute of Public Health has found
an increase in the use of both cephalosporins and quinolones
in Norway during our study period [16]. This may also have
contributed to the increased resistance of CoNS found in
infected THA.
Other studies of PJI in hip- and knee arthroplasty have
found the proportion of MRSE among bacterial infections to
be 62–72% [2, 3, 17, 18]. Our findings of 70%MRSE are similar
to these findings.
Dale et al. found a 3-fold increased risk of revision due
to THA infection during the time period 2003–2007 com-
pared to the time period 1987–1992 [6]. In an editorial com-
ment to Dale’s paper, Walenkamp raised the question of
whether increased bacterial resistance could be part of the
explanation [8]. Our findings support Walenkamp’s opinion
that increased prevalence of MRSE could be a part of the
explanation.








































































































































































































































































































































































































































































































































Figure 2: Development of resistance in coagulase-negative staphylococci towards selected antibiotics. Percent resistance is present on the
𝑦-axis, time period on the 𝑥-axis. (1) Significant increase in resistance for methicillin, clindamycin, and cotrimoxazole (𝑃 < 0.05). (2) Not
significant increase in resistance for aminoglycosides (𝑃 = 0.15).
We found a high proportion of CoNS and enterococci
resistant to the aminoglycosides. A trend towards increasing
aminoglycoside resistancewas foundwithCoNS,whereas the
resistance was more or less unchanged for the other bacteria.
Interestingly, Fulkerson found a higher rate of susceptible
CoNS for aminoglycosides in a cohort from New York and
Chicago (87%) compared to our Norwegian patients (51%)
[19]. The explanation for this difference could be that in
Norway gentamicin-loaded bone cement was used in most
primary THAs. In contrast, in the United States cementless
implants are predominant, and when bone cement is used in
primary surgery, it mostly does not contain antibiotics [20].
We found no methicillin-resistant S. aureus (MRSA). In
Norway, there is a very low incidence of MRSA compared
to most other countries [4]. In an English study, an MRSA
prevalence of 8% was found. In a study from Australia, a
prevalence of 11%MRSAwas found (6/53) [2, 3]. In a Swedish
study of infected knee implants only 1/84 of the causal
bacteria were MRSA, reflecting the low incidence of MRSA
also in another Scandinavian country [17]. The favorable
resistance patterns of S. aureus are also reflected by the lack
of resistance to aminoglycosides, linezolid, rifampicin, cotri-
moxazole, and quinolones, and only sporadic cases of resis-
tance to macrolides, clindamycin, and fusidic acid.
The incidence ofmethicillin resistance is higher for CoNS
than S. aureus. In Norway, strict measures have been taken to
prevent the spread of MRSA, similar to the Netherlands, and
these programs have been successful thus far [21]. Preventing
the spread of MRSE has proven more difficult [22].
Limitations. The present study has some limitations. It is a
retrospective study based on data from a national registry.
However, our data on revisions due to infection after THA
were prospective, and the NAR has been found to have good
completeness [23, 24]. Since we used the NAR to identify
cases of infection for the purpose of collecting bacteriological
data, and the hospitals were different in types and spread all
over the country, we expect the selection bias to be minor.
Hence, we assume that our findings are representative for the
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susceptibility patterns with bacteria causing infected THAs in
Norway over the study period.
The diagnosis of infection was based on perioperative
assessment by the orthopaedic surgeon, before culturing
results of intraoperative tissue samples were available. Since
only cases with growth of the same bacteria in two or more
tissue samples were included, all revisions included in the
present study should be true PJIs. However, these strict crite-
ria led to a high amount of reported revisions disqualified due
to no growth or only one positive sample. We did not include
preoperative joint fluid collection, as we first and foremost
wanted our included revisions to be true PJIs, and we wanted
full susceptibility charts. Also, PJIs treated with debridement
without change of liner or head, or antibiotic suppression
therapy alone, were not reported to the NAR and thus not
included in the present study.
Clinical Implications. In Norway, the common practice is to
use cephalothin as systemic prophylaxis during surgery and
gentamicin in bone cement as local prophylaxis for cemented
THAs [25]. The most common empirical antibiotic therapy
for suspected PJI has been a combination of cloxacillin and
gentamicin.With 84%methicillin resistance and 67% amino-
glycoside resistance for CoNS during the last time period,
treatment failure could be the result of inadequate antibiotic
coverage. Thus, preoperative sampling, such as aspiration or
biopsy, is crucially important, especially in low-grade infec-
tions. Under these circumstances, the patients are normally
nonseptic, and there is time to await the culture results before
surgical and medical treatment of the infection. The second
most commonpathogen, S. aureus, is fully susceptible to both
the prophylactic regimen and the empirical treatment.
The antibiotic treatment must be adjusted to the bacteri-
ological findings. When MRSE is proven or likely the cause
of infection, vancomycin should be added to bone cement or
spacers if used in revision surgery and should also be part
of the systemic treatment [26]. The newly published national
guidelines for use of antibiotics in hospitals from The Nor-
wegian Directorate of Health have now advocated the use of
vancomycin as empirical treatment for PJI, partly based on
data from our study [27].
5. Conclusion
We identified an increase in the proportion of PJI-causing
methicillin-resistant CoNS over the study period. Adequate
bacterial sampling is crucial for choosing the right antibiotic
treatment. This is increasingly important given the emerging
resistance of CoNS found in PJI in the present study.
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Söreide, “Validation of data in the norwegian arthroplasty
register and the norwegian patient register: 5,134 primary total
hip arthroplasties and revisions operated at a single hospital
between 1987 and 2003,” Acta Orthopaedica, vol. 76, no. 6, pp.
823–828, 2005.
[25] L. B. Engesæter, B. Espehaug, S. A. Lie, O. Furnes, and L.
Havelin, “Does cement increase the risk of infection in primary
total hip arthroplasty? Revision rates in 56,275 cemented and
uncemented primary THAs followed for 0-16 years in the
Norwegian Arthroplasty Register,” Acta Orthopaedica, vol. 77,
no. 3, pp. 351–358, 2006.
[26] A. Trampuz and W. Zimmerli, “Diagnosis and treatment of
implant-associated septic arthritis and osteomyelitis,” Current
Infectious Disease Reports, vol. 10, no. 5, pp. 394–403, 2008.
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Rationale, aims, and objectives: The true effect of laminar airflow (LAF) systems on
postoperative infection is disputed, partly due to uncertainty regarding the validity of
ventilation data in register studies. The aim of this study was to validate the informa-
tion on operating room (OR) ventilation reported by the orthopaedic surgeons to the
Norwegian Arthroplasty Register (NAR) after primary total hip arthroplasty (THA).
Method: Forty of the 62 public orthopaedic units performing primary THA in Nor-
way during the period 1987‐2015 were included. The hospitals' current and previous
ventilation systems were evaluated in cooperation with the hospitals head engineer.
We identified the type of ventilation system reported to the NAR and compared
the information with the factual ventilation in the specific ORs at the time of primary
THA.
Results: A total of 108 067 primary THAs were eligible for assessment. None of the
hospitals performed THA in true “greenhouse” (GH) ventilation. Fifty‐seven percent
of the primary THAs were performed in ORs with LAF and 43% in ORs with conven-
tional, turbulent ventilation (CV). Comparing the reported data with the validated
data, LAF was reported with a sensitivity of 86%, specificity of 89%, and positive pre-
dictive value (PPV) of 92%, with an accuracy of 88%. CV was reported with a sensi-
tivity of 89%, specificity of 87%, and PPV of 84%, with an accuracy of 88%. The total,
mean misreporting rate was 12%.
Conclusions: Surgeons were not fully aware of what kind of ventilation system
they operated in. This study indicates that conclusions based on ventilation data
reported on THA in the NAR should not be interpreted without considering the inac-
curacy of the data.
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1 | INTRODUCTION
Laminar airflow (LAF) systems have been used in operating rooms
(ORs) for ultraclean surgery since the late 1950s. The intention is to
reduce the incidence of postoperative infection by reducing the col-
ony forming unit (CFU) density in the air of the OR.1,2 The systems
work by sending linear and parallel streams of clean air with constant
velocity, directly on to the surgical field in order to, in theory, displace
and reduce the flow of less clean air to the surgical field. In contrast,
the conventional ventilation (CV) systems mostly use the dilution prin-
ciple and work by creating an overpressure using turbulent air.3 The
LAF systems are, however, rarely able to create true LAF3 and are
therefore more recently designated as unidirectional airflow (UDAF
or UDF) systems; but for simplicity, we will use the designation LAF
in the present paper.
The existing recommendations of LAF as a prophylactic measure of
postoperative infection, rest mainly on a randomized trial from a time
when standards on antibiotic prophylaxis were not fully established,
and was therefore not thoroughly adjusted for. The findings therefore
may not apply for the current situation.4 Subsequent observational
studies from the same decade that adjusted for antibiotic prophylaxis
demonstrated no influence of OR ventilation on the rate of postoper-
ative infection.5,6 Newer, registry‐based studies have suggested that
LAF actually increases the risk of postoperative infection.7-9 A recent
systematic review and meta‐analysis in the Lancet, based partly on
the above mentioned registry studies, concluded that LAF systems
should not be installed in new ORs.10 The conclusion is controversial
and may be premature.11,12 The Lancet review also includes a study
from the Norwegian Arthroplasty Register (NAR), not studying the
effect of LAF specifically, and which may be confounded by
misreporting.13
Before concluding rigorously in systematic reviews and meta‐anal-
yses, it is of fundamental importance that ventilation data are valid
and of good quality. The aim of the present study was to validate
the data on OR ventilation reported on primary total hip arthroplasty
(THA) cases to the NAR.
2 | MATERIAL AND METHODS
The NAR has registered individual data on primary THAs and THA
revisions since 1987. The surgeon fills in a form immediately after sur-
gery. The form contains information on patient identity, date of oper-
ation, the type of OR ventilation in addition to several other patient,
and surgery‐related factors. For each hospital, we used the NAR to
identify the type of OR ventilation reported for the primary THA, ie,
CV, LAF, or greenhouse (GH) ventilation (register form, Appendix A).
The period of inclusion was 1 September 1987 to 31 December 2015.
In order to validate the information on OR ventilation reported by
the surgeon, the hospitals' current and previous ventilation systems
were evaluated in direct contact and cooperation with the hospitals
NAR contact‐surgeon and the hospitals head engineer. Six hospitals
in a pilot study were visited in order to gain knowledge on the differ-
ent systems and method of data collection. The factual ventilation sys-
tems in the ORs were assessed using a detailed questionnaire
regarding the configuration and specifications of the ventilation sys-
tems (Appendix B). The questionnaire was used as guidance in the cor-
respondence with the engineers. Objective, technical specifications
from manuals were retrieved in cases of doubt. To be classified as a
LAF system, the ventilation set‐up had to be confirmed to have been
installed with a unidirectional diffuser array. These criteria are not suf-
ficient to verify true LAF conditions, but in this paper, the main issue
was whether the system was installed with a unidirectional diffuser
array or not, in order to do a direct comparison with the reported data.
To assess the correspondence between the reported and validated
ventilation data, we did a case‐to‐case comparison of the OR in which
each reported, primary THA was performed. The accuracy of
reporting, based on sensitivity and specificity for each ventilation
group, was then calculated.
If the ventilation system had been out of function, exchanged, or
updated, primary THAs reported from that year were excluded.
Sixty‐two public hospitals reported to the register in the period.
Twelve hospitals were excluded due to low numbers of primary THAs
or concurrent use of ORs with different ventilation systems. Fifty hos-
pitals were selected for inclusion. Five hospitals were excluded due to
missing contact with key personnel and five due to incomplete venti-
lation data (Figure 1). Forty hospitals had precise information on the
FIGURE 1 Flow chart showing hospital and total hip arthroplasty
(THA) selection
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OR ventilation, and these 40 hospitals reported 108 067 primary
THAs available for validation.
2.1 | Statistics
The sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV), accuracy of reported data, and misreporting
rate were calculated as presented in Figure 2. Statistical analyses were
performed using SPSS version 24 (SPSS Inc, 2004).
2.2 | Ethics
The registration of data and the study was performed confidentially on
patient consent and according to Norwegian and EU data protection
rules.
3 | RESULTS
A total of 108 067 primary THAs were included in the further analysis.
TheseTHAs constituted 66% of theTHAs reported to the NAR during
the study period; 57 % of the surgeries were performed in a room with
verified LAF, and 43% were performed in rooms with roof‐mounted,
verified CV. None of theTHAs were performed in true GH conditions.
Figure 3 gives a summarized comparison between the reported OR‐
ventilation and the factual OR ventilation. LAFwas reportedwith a sen-
sitivity of 86%, specificity of 89%, and Positive Predictive Value (PPV)
92%. This gave an accuracy of 88%. CV was reported with a sensitivity
of 89%, specificity of 87% and PPV of 84%, with an accuracy of 88%.
This gave a total misreporting rate of 12% for both LAF and CV.
4 | DISCUSSION
We found 12% misreporting of the OR ventilation used during primary
THA reported to the NAR.
FIGURE 2 Formulas for calculating measures. FP, false positive; FN, false negative; TN, true negative; TP, true positive
FIGURE 3 Comparison between surgeon‐reported ventilation data and validated ventilation data. CV, conventional ventilation; FN, false
negative; FP, false positive; GH, greenhouse ventilation; LAF, laminar airflow; NPV, negative predictive value; PPV, positive predictive value;
TN, true negative; TP, true positive
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Other registries have studied the preventive effect of LAF systems.
All of these studies are included in the latest meta‐analysis published
in The Lancet.10 Two studies based on data from The German KISS
(Krankenhaus [hospital] Infections Surveillance System) registry
showed an increased risk of severe surgical site infection (SSI) after
THA operated in LAF conditions compared with CV.7,9 They gathered
information on the different ventilation systems by using a question-
naire, where data were provided by the surgical departments. To
which degree these data were validated or from whom the data were
reported remains unclear. The New Zealand Joint Registry reported an
increased risk of revision due to deep infection after THA performed
in an LAF theatre.8 They validated the reported information by asking
the hospitals to confirm what kind of ventilation system they used. It
was not stated what kind of personnel answered these questions. Also
included in the latest meta‐analysis was a study from the NAR,13 using
invalidated, surgeon reported data on ventilation. In that NAR study,
OR ventilation was used only as an adjustment variable in the study
of time trends for revision due to infection. The relative risk of revision
due to infection was found to be 1.3 (95% CI, 1.1‐1.5) for LAF com-
pared with CV. The above mentioned studies contribute to the basis
for the new WHO‐guidelines,14 which recommend not to use LAF
for arthroplasty. Taking the results of our study into consideration, this
recommendation may be considered controversial, as the evidence is
of uncertain validity and quality.
4.1 | Strengths
The validated ventilation data, presented in the present study, is
based on a large, national registry, with 100% coverage and 97%
completeness in the reporting of primary THA.15-17 It offers an
opportunity to validate a majority of a national cohort from a long
period of time.
The validated data were based on the information retrieved from
the engineers responsible for the hospitals ventilation systems, and
this information was verified by the NAR contact surgeon. In addition,
in order to overcome possible reporting bias, we retrieved objective,
technical data from manuals and specifications on the hospitals venti-
lation in cases of doubt. Only indubitable information was included,
and hospitals with uncertain information were excluded.
4.2 | Potential weaknesses
Only 40 hospitals, representing 66% of the primary THAs reported to
the NAR, were eligible for validation of OR ventilation. Like the 40
included hospitals, the 22 excluded hospitals had THA activity
throughout the majority of the time period and a similar distribution
between local hospitals, regional hospitals, and elective centres. The
excluded hospitals also had similar completeness of reporting of pri-
mary THA and OR ventilation.16,17 Hence, we believe that the selec-
tion bias was minimal.
5 | CONCLUSION
Surgeons were not fully aware of what kind of ventilation system they
operated in when performing primary THA. This resulted in a 12%
misreporting rate for both CV and LAF systems. This indicates that
conclusions based on ventilation data in the NAR should not be
interpreted without considering the inaccuracy of the data as the sub-
sequent evaluations of the prophylactic effect of ventilation systems
against postoperative infection may turn out inaccurate.
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S U M M A R Y
Background: The air in the operating room is considered a risk factor for surgical site
infection (SSI) due to airborne bacteria shed from the surgical staff or from patients
themselves.
Aim: To assess the influence of validated operating room (OR) ventilation data on the risk
of revision surgery due to deep infection after primary total hip arthroplasty (THA)
reported to the Norwegian Arthroplasty Register (NAR).
Methods: Forty orthopaedic units reporting THAs to the NAR during the period 2005e2015
were included. The true type of OR ventilation in all hospitals at the time of primary THA
was confirmed in a previous study. Unidirectional airflow (UDF) systems were subdivided
into: small, low-volume, unidirectional vertical flow (lvUDVF) systems; large, high-volume,
unidirectional vertical flow (hvUDVF) systems; and unidirectional horizontal flow (UDHF)
systems. These three ventilation groups were compared with conventional, turbulent,
mixing ventilation (CV). The association between the end-point, time to revision due to
infection, and OR ventilation was estimated by calculating relative risks (RRs) in a mul-
tivariate Cox regression model, with adjustments for several patient- and surgery-related
covariates.
Findings: A total of 51,292 primary THAs were eligible for assessment. Of these, 575 had
been revised due to infection. A similar risk of revision due to infection after THA per-
formed was found in ORs with lvUDVF and UDHF compared to CV. THAs performed in ORs
with hvUDVF had lower risk of revision due to infection compared to CV (RR ¼ 0.8; 95% CI:
0.6e0.9; P ¼ 0.01).
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Conclusion: THAs performed in ORs with hvUDVF systems had lower risk of revision due to
infection compared to THAs performed in ORs with CV systems. The perception that all
UDF systems are similar and possibly harmful seems erroneous.
ª 2020 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
Infection after total hip arthroplasty (THA) is devastating for
the patients and generates high public costs [1]. The air in the
operating room (OR) is considered a potential source of con-
tamination and subsequently a risk factor for surgical site
infection (SSI) due to airborne bacteria and other viable micro-
organisms (colony-forming units (cfu)) shed from the surgical
staff or from patients [2e7]. The number of cfu in the OR may
be altered by staff behaviour such as the number of personnel,
door openings, and physical movement, and by the use of other
preventive measures such as impermeable gowns and space
helmets [8e10]. Previous studies have postulated that the
density of cfu is correlated with the rate of postoperative
infection, but the findings are controversial as the isolated
effect of air cleanliness is hard to assess [6,11e15]. Other
studies show that air contamination is not directly associated
with wound contamination and periprosthetic joint infection
[16,17].
Unidirectional airflow (UDF or UDAF) systems (formerly
known as laminar airflow (LAF) systems) have been used during
ultraclean surgery since the late 1960s, as they were thought to
reduce the incidence of SSI by reducing the cfu density [13].
UDF systems work by sending parallel, filtered air streams with
constant velocity directly on to the surgical field to intention-
ally displace and reduce the flow of less clean air from the rest
of the OR to the surgical field. This is in contrast to the con-
ventional ventilation (CV) systems, which use the dilution
principle. CV systems supply turbulent air in order to dilute
airborne contamination, mixing polluted air with clean air, and
are often termed turbulent and/or mixing ventilation systems
[18].
Unidirectional airflow as a prophylactic measure against SSI
has been supported ever since Lidwell and colleagues pub-
lished their randomized, clinical trial in the 1980s [19]. For THA
and total knee arthroplasty (TKA), they found lower risk of
‘deep joint sepsis’ after arthroplasty performed in ultra-clean
air (UCA; cfu <10/m3) with a relative risk (RR) of 0.4 compared
to a control group with non-ultra-clean air. The study has been
criticized for having methodological weaknesses, but both
historic and recent re-evaluations of the study confirm the
validity of the findings [15,20e23]. Subsequent observational
studies from the same decade, controlled for antibiotic pro-
phylaxis, found no convincing influence of OR ventilation on the
rate of SSI [24,25]. More recently, studies from surveillance
registries have suggested that LAF actually may increase the
risk of infection after arthroplasty [26e28]. Two recent sys-
tematic reviews, based partly on these registry studies, con-
clude that UDF systems should not be installed in new ORs
[20,29]. One of the reviews includes an observational study
from the Norwegian Arthroplasty register (NAR), not studying
the effect of UDF specifically, using ventilation only as an
adjustment variable in the study of infection trend [30]. In a
previous validation study, we found 12% misreporting of ven-
tilation data to the NAR, questioning the validity of studies
based exclusively on ventilation data reported from surgeons
or surgical departments [31]. In addition, there are numerous
different configurations of UDF systems, and when studying
their effect on the rate of postoperative infections it is
important to know the dissimilarities between the different
UDF systems and that these have evolved over the decades.
Our aim in the present study was to assess the association
between validated, factual OR ventilation systems and the risk
of revision due to deep infection after primary THA.
Methods
Since its inception in 1987, the NAR has registered data on
primary and revision THAs in Norway. The register form is filled
in by the surgeon immediately after surgery, containing infor-
mation on patient identity, date of operation, indication for
surgery and other surgery-related factors. In addition, certain
patient-related factors such as sex, age, and comorbidity are
registered. Primary THA and any subsequent revisions are
linked through a unique person identity number that follows
each citizen from birth to death. Revision is defined as removal
or exchange of prosthesis parts, whereas revision cause, i.e.
deep infection, is determined by the surgeon based on peri-
operative assessments and clinical evaluation. Cases of revision
due to infection are thus reported to the NAR before the cul-
turing of peroperative tissue samples is ready. The data is
validated, with 97% completeness of reporting of primary
THAs, 93% reporting of revisions, and 100% coverage of Nor-
wegian hospitals [32].
The factual OR ventilation on each hospital was validated
and either confirmed or corrected in a previous study [31]. To
be included as a UDF system, it had to be verified that the
system had been installed with a multistage high-efficiency
particulate air (HEPA)-filtered, unidirectional diffuser array.
Based on technical data collected, the following classification
of ventilation systems was established for further analyses:
small, low-volume, unidirectional, vertical flow systems
(lvUDVF: volume flow rate (VFR; m3/h) <10,000 and canopy
size (m2) <10); large, high-volume, unidirectional, vertical
flow systems (hvUDVF: VFR 10,000 and canopy size 10); and
unidirectional horizontal flow (UDHF). We did not have com-
plete data on the volume of each OR, so we were unable to
calculate the exact air changes per hour (ACH). As the ACH also
might be dependent on other factors, we did not include ACH in
the definition of the different UDF systems. The CV systems
included in this study were verified to fulfil the requirement of
multi-stage HEPA-filtered air with 20 ACH and positive pres-
surization [33].
The period of inclusion was 2005e2015, primarily due to the
fact that the patients’ American Society of Anesthesiologists
(ASA) class, a risk factor associated with infection, was only
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reported to the NAR from 2005 and onwards [34]. All patients
during this period received systemic, antibiotic prophylaxis.
A separate survey confirmed negligible use of space suits
and/or helmets. Three of the hospitals used space suits in very
short periods of time, but discontinued the use due to loss of
spatial awareness.
Validated ventilation data were obtained for 40 out of 62
public hospitals reporting THAs to the NAR in the inclusion
period [31]. Out of 60,298 THAs performed in these 40 hospi-
tals, 2046 were performed in a period of ventilation system
exchange or update, and were excluded. A total of 4313 THAs
performed in UDVF ventilation were excluded due to lack of
detailed information on certain ventilation covariates from
parts of the inclusion period, essential for our main analyses, or
due to the current UDVF system not fulfilling the defined cri-
teria for lvUDVF or hvUDVF. In addition, 2647 THAs were
excluded due to missing patient or procedure covariates.
Hence, 51,292 THAs were eligible for analyses.
Statistics
The association between OR ventilation and revision due to
infection was estimated by Cox regression analyses. Relative
risk (RR), as a measure of hazard rate ratios, was calculated
with 95% confidence intervals (CIs). End-point was date of
revision due to deep infection. Further, adjusted four-year
survival rates were calculated, as well as KaplaneMeier four-
year survival rates, and cumulative survival curves with OR
ventilation as strata. In the multivariate analyses, we adjusted
for sex, age at primary surgery, indication for primary THA, ASA
class, method of fixation, modularity of the prosthesis, and
duration of surgery. Year of primary THA was included as an
adjustment variable to account for unknown time dependent
confounding. Additional analyses were made with one- and
two-year follow-up. Further, additional assessments were
performed to adjust for spatial orientation of the wound in the
OR, whether the wound was oriented upwards or to the side,
based on an evaluation of patient positioning and surgical
approach as potential risk factors. The analyses were per-
formed in concordance with the guidelines for statistical
analyses of arthroplasty register data [35]. P < 0.05 and non-
overlapping 95% CIs were considered statistically significant.
Statistical analyses were performed using SPSS version 24
(SPSS Inc., 2004) and R (R Foundation for Statistical Computing,
2014). The study was performed in accordance with the
RECORD and STROBE statements.
Ethics
The registration of data and further assessment were per-
formed confidentially following patient consent and according
to Norwegian and EU data protection rules.
Results
Among the 51,292 eligible THAs, 575 (1.1%) had been revised
due to infection. Demographics and distribution of risk factors
in the different ventilation groups are presented in Table I. All
patients received systemic antibiotic prophylaxis and all
cemented THAs had antibiotic loaded bone cement. The dis-
tribution of the risk factors was similar for the four ventilation
groups, except for more uncemented THAs in the two hospitals
using UDHF (one rural and one regional hospital). In the
remaining three ventilation groups, rural, regional, university,
and specialized elective hospitals were evenly represented.
During the study period, four hospitals converted from CV to
hvUDVF and one hospital converted from lvUDVF to hvUDVF
between 2006 and 2009. From 2009, 16 hospitals used CV, nine
used lvUDVF, and 13 used hvUDVF systems. The annual dis-
tribution of THAs within the different groups of ventilation
system is presented in Figure 1. The risk factors and con-
founders in the adjusted analyses are presented in Table II.
Sex, age, ASA class, and duration of surgery were associated
with risk of revision due to infection.
Table I
Baseline characteristics for the total hip arthroplasties performed
in the different ventilation systems
Characteristic Type of operating room ventilation
Conventional lvUDVF hvUDVF UDHF
No. of THAs 17,297 12,639 17,960 3396
Sex
Male 34% 33% 34% 33%
Female 66% 67% 67% 67%
Age group (years)
<45 2% 3% 3% 3%
45e54 6% 7% 8% 7%
55e64 22% 23% 23% 22%
65e74 36% 36% 36% 35%
75e84 28% 27% 25% 28%
>85 5% 5% 5% 5%
Indication for primary THA
Osteoarthritis 82% 75% 77% 83%
Inflammatory disease 3% 3% 2% 2%
Hip fracture 3% 2% 3% 1%
Complication after hip
fracture
6% 6% 6% 5%
Complication after
childhood hip disease
5% 12% 10% 6%
Necrosis of the femoral
head
2% 2% 3% 3%
ASA class
1 22% 18% 19% 19%
2 57% 63% 61% 62%
3 21% 19% 20% 19%
Method of fixation
Uncemented 20% 9% 29% 64%
Cemented 80% 91% 71% 36%
Modularity of the prosthesis
Monoblock 5% 5% 4% 0
Modular 95% 95% 96% 100%
Duration of surgery (min)
<70 20% 20% 27% 18%
70e99 51% 41% 36% 48%
100e129 21% 28% 27% 27%
>130 8% 11% 10% 7%
lvUDVF, small, low-volume, unidirectional vertical flow systems;
hvUDVF, large, high-volume, unidirectional vertical flow systems;
UDHF, unidirectional horizontal flow systems; THA, total hip arthro-
plasty; ASA, American Association of Anesthesiologists.
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Assessing the UDF group as one encompassing entity, pri-
mary THAs performed in ORs with such unclassified UDF had a
risk of revision due to infection similar to that of CV (RR: 0.9;
95% CI: 0.7e1.2). The risk of revision due to infection after
THAs performed in ORs with lvUDVF and UDHF was similar to
those performed in CV (Table III, Figure 2). THAs performed in
ORs with hvUDVF had a lower risk of revision due to infection
than those performed in CV (Table III, Figure 2). No UDF system
was associated with higher risk of revision due to infection
after THA compared to CV.
Adjusting for wound spatial orientation and reducing follow-
up time to one year and two years had only minor influences on
the results. We did not have complete data on the spatial
volume of all ORs in order to calculate the exact ACH, but
adjusting for operating room volume in analyses of the avail-
able ORs had negligible impact on the results.
Discussion
The risk of revision due to infection after primary THA
performed in ORs with hvUDVF was 20% lower than after THA
performed in CV, whereas THA performed in ORs with lvUDVF or
UDHF had a risk of revision due to infection similar to that of
THA performed in CV. No UDF system was associated with
higher risk of revision due to infection after THA compared to
CV.
Recent registry studies as well as systematic reviews and
meta-analyses are questioning the effect of LAF/UDF as a
prophylactic measure against postoperative infection, as they
suggest for arthroplasty an increased risk of SSI and revision
due to infection [20,26e30]. This is in contrast to the results
from our study on validated ventilation data. Recent World
Health Organization (WHO) guidelines, though conditional,
recommend not to use UDF systems to reduce the risk of SSI in
arthroplasty [36]. The WHO recommendation is based partly on
a few observational studies with some methodological issues:
no UDF system differentiation or definition based on technical
specifications, limited documentation of validation on the UDF
systems, and limited information on coverage or completeness
of reporting of the end-point SSI or revision due to infection
[21,22,31,37]. Some of these studies had only six months to one
year follow-up, and others had no systematic post-discharge
surveillance. This has been a point of debate as low-grade
infections caused by airborne contaminants might be exclu-
ded as they may present at a much later stage [21,22].
Coagulase-negative staphylococci (CoNS) are the most fre-
quent bacterial cause of revision of infected THA [38]. Since
CoNS are regarded as commensal bacteria and since CoNS have
also been shown to be the most frequent bacterial cause of late
infection, this may suggest that direct contamination from
primary surgery is the likely mechanism of THA infection, even
in infection more than two years after primary THA [38].
Haematogenous seeding of CoNS is possible, but is less likely to
occur as this requires substantial bacteraemia [39,40]. We
studied the effect of OR ventilation with four years follow-up,
comparable to the Lidwell studies [21,41].
One possible explanation for the reported contrary effect of
UDF could be improper positioning and movement of person-
nel, theatre lamps, etc. in the airflow [18,42,43], thereby
abolishing the preventive effect by creating more turbulence.
This might especially be the case in the boundary areas due to
insufficient size of the protected UDF zone. Studies have shown
impact of canopy size on bacterial counts in the surgical area,
where the minimum size of a UDF ceiling distribution system
has been recommended to be at least 320320 cm for ultra-
clean surgery [44e46]. We studied the effect of canopy size on
infection risk by defining cut-off for canopy size in accordance
with this recommendation.
In addition, the potentially lower tissue temperature and








2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
















Figure 1. Annual number of primary THAs in the four different ventilation groups during 2005e2015. UDHF, unidirectional horizontal flow
systems; hvUDVF, large, high-volume, unidirectional vertical flow systems; lvUDVF, small, low-volume, unidirectional vertical flow
systems.
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wound’s own protective, thermal plume, is also claimed to
disturb the effectiveness of the UDF [26,47e49]. One recent
study identifies the use of UDF as a significant risk factor for
hypothermia, thereby being subsequently a risk factor for
infection of the wound [50,51]. To counteract these issues,
forced air warming (FAW) systems have been used. These are
also thought to disturb the laminar airflow [52,53]. However,
recent reviews conclude that the evidence for this is sparse
[54e56]. A recent experimental study found that the dis-
turbing effect of FAW is counteracted by sufficient air
velocity in the UDF systems [57]. As the air velocity of dif-
ferent UDF systems is adjustable, we could not use it as a
constant adjustment variable in our analyses. It was there-
fore indirectly assessed by studying the VFR, varying in the
range of 1000e5000 m3/h in older, low-volume systems and
10,000e20,000 m3/h in newer, high-volume systems. The
latter is necessary to create velocities in the desired mini-
mum range of 0.3e0.38 m/s through large area canopies
[58].
UDF systems are able to create lower cfu concentrations
than CV systems both in air and close to the operation site. This
is shown both in computational fluid dynamics studies and in
experimental studies [44,59e66]. Studies have also shown an
association between the cfu concentration and SSI, but the
question remains whether other risk factors such as the
patient’s immunological status, bacterial virulence, antibiotic
prophylaxis, surgical technique, etc., are indeed much more
important [6,11e14]. The latter is supported by studies show-
ing that SSI after elective orthopaedic surgery is more fre-
quently caused by endogenous transmission than previously
assumed [67,68]. Further indicating the patients’ skin com-
mensals as source of infection are studies on the bacteriology
of infected shoulder arthroplasty and postoperative infections
after spinal surgery, showing a high proportion of Propioni-
bacterium (Cutibacterium) acnes [69e71]. This is a species
known to be abundant in sebaceous glands of the skin in such
regions, and as the bacteriology of infected total hip arthro-
plasties is different, dominated by staphylococci, this might
indicate that the patients are their own source of infection. If
the cleanliness of the air in the OR is the same during different
types of prosthetic surgery and a significant source for post-
operative infection, why does the bacteriological spectrum of
Table II
Relative risks of revision due to infection after primary total hip arthroplasties in the Norwegian Arthroplasty Register
Risk factor Included Revised due to infection Relative risk 95% CI P-value
Sex
Male 17,144 268 1.8 1.5e2.1 <0.001
Female 34,148 307 1
Age group (years)
<45 1334 15 1.2 0.7e2.1 0.5
45e54 3667 27 0.8 0.5e1.3 0.4
55e64 11,584 101 0.9 0.7e1.2 0.6
65e74 18,475 180 1
75e84 13,669 202 1.5 1.2e1.8 <0.001
>85 2563 50 1.9 1.4e2.7 <0.001
Indication for primary THA
Osteoarthritis 40,305 448 1
Inflammatory hip disease 1293 18 1.3 0.8e2.1 0.3
Hip fracture 1180 17 1.3 0.8e2.1 0.3
Complication after hip fracture 2963 39 1.0 0.7e1.4 0.9
Complication after childhood hip disease 4342 31 0.8 0.5e1.2 0.2
Necrosis of the femoral head 1209 22 1.5 1.0e2.3 0.08
ASA class
1 10,178 60 0.6 0.5e0.8 <0.001
2 30,837 347 1
3 10,276 168 1.3 1.1e1.5 0.02
Method of fixation
Uncemented 11,974 127 1.0 0.8e1.2 1.0
Cemented 39,318 448
Modularity of the prosthesis
Monoblock 2059 11 0.5 0.3e1.0 0.04
Modular 49,233 564 1
Duration of surgery (min)
<70 11,405 120 1.1 0.9e1.4 0.4
70e99 22,125 225 1
100e129 12,935 147 1.1 0.9e1.4 0.3
>130 4827 83 1.6 1.3e1.8 0.002
CI, confidence interval; THA, total hip arthroplasty; ASA, American Association of Anesthesiologists.
Adjusted for sex, age, indication for primary THA, ASA class, modularity of the prosthesis, method of fixation, and duration of surgery, in addition to
operating room ventilation and year of primary THA.
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infections vary between different regions of the body? This
questions the extent of air cleanliness importance. Despite
this, and with increasing antibiotic resistance taken into
account, it seems logical to reduce the peroperative, bacterial
load to a minimum. This will be increasingly important in an era
with increasing microbial resistance to antibiotics [72,73].
Our finding of a 20% lower risk of revision due to infection
after THA performed in hvUDVF compared to CV is minute,
considering also that the incidence of revision due to infection
is only around 1%. However, UDF systems can create cleaner
air, and, taking our results into account, it seems erroneous to
discontinue the use of large, high-volume, vertical UDF systems
in the ORs of the future. Technological development and
multidisciplinary co-operation with the focus on correct
implementation and function of the ventilation systems should
be encouraged [22,65,66].
Our study is based on data from the NAR with a large number
of THAs, with good quality, coverage, and completeness
[74e76]. This gives us a unique opportunity to study relatively
rare events, such as deep infection after THA, with detailed
information on surgery- and patient-related confounders.
Other register studies on OR ventilation have been criticized
for not making a thorough adjustment of antibiotic prophy-
laxis, for using surgeon- or surgical department-reported data
on ventilation, for not differentiating the UDF systems on
technical specifications, and for having a limited follow-up
time [21]. All of our cases received systemic, antibiotic pro-
phylaxis and the multivariate analyses were conducted on the
basis of validated ventilation data. Further, we did sub-
analyses on canopy size and VFR with four-year follow-up. All
this adds strength to our study and makes it a substantial
contribution to new knowledge in the field.
This study suggests merely the association between OR
ventilation and revision due to deep infection after primary
THA. There will be unknown confounding such as human
behavioural factors in the OR, incorrect implementation and
maintenance of the ventilation systems, and other factors
potentially disturbing the UDF. We have no information on
patient warming systems, use of surgical drapes, number of
personnel in the room, number of door openings, etc., but we
have no reason to believe that this would be different between
the four ventilation groups in our study. In addition, revision
due to infection may be underreported, but, as the under-
reporting of revision is similar between the hospitals, this will
add minimal selection bias and subsequent impact on our
results [32,77e79].
There has been an increase in the share of hvUDVF systems
over the last 20 years (Figure 1). This increase is parallel to the
reported, increased risk of revision due to infection after THA
[80,81]. This will necessarily be a time-dependent confounder
in our analyses and we have addressed this by adjusting for year
of primary surgery as a continuous variable in the analysis.
Only two of the included hospitals used UDHF. In addition,
these two hospitals had a higher share of uncemented THAs.
This may add selection bias, but the type of fixation was
adjusted for.
Themodularity of the prosthesis may affect the incidence of
reported revision due to infection. Non-modular/monoblock
THAs (i.e. Charnley prostheses) were used by some hospitals
until 2014. They do not contain modular parts, and hence,
infections of such THAs treated with debridement, antibiotics,
and implant retention (DAIR) were not reported to the NAR
until 2011 from when all DAIRs were reported regardless of
component exchange or not. This is in contrast to modular
THAs, which contain removable components exchanged during
a DAIR procedure. Hence, these debridements were defined as
revisions throughout the study period, and were subsequently
Table III
Relative risks of revision due to deep infection after primary total hip arthroplasty, adjusted four-year survival and KaplaneMeier four-year























Conventional 17,297 208 1 98.8 (98.6e98.9) 98.9 (98.7e99.0) 1627 12,914
lvUDVF 12,639 138 0.9 0.7e1.1 0.3 98.9 (98.7e99.0) 99.0 (98.9e99.2) 1081 9077
hvUDVF 17,960 175 0.8 0.6e0.9 0.01 99.0 (98.9e99.2) 99.1 (99.0e99.3) 1423 11,860
UDHF 3396 54 1.3 0.9e1.8 0.1 98.4 (97.9e98.8) 98.6 (98.2e99.0) 342 2366
THA, total hip arthroplasty; CI, confidence interval; lvUDVF, small, low-volume, unidirectional vertical flow systems; hvUDVF, large, high-volume,
unidirectional vertical flow systems; UDHF, unidirectional horizontal flow systems.
Adjustments were made for sex, age, indication for primary THA, American Association of Anesthesiologists class, modularity of the prosthesis,






















Figure 2. Survival curves for total hip arthroplasties (THAs) per-
formed with different ventilation systems and revised due to
infection. Adjusted for sex, age, indication for primary THA,
American Association of Anesthesiologists class, modularity of the
prosthesis, method of fixation, duration of surgery, and year of
primary THA. lvUDVF, small, low-volume, unidirectional vertical
flow systems; hvUDVF, large, high-volume, unidirectional vertical
flow systems; UDHF, unidirectional horizontal flow systems.
H. Langvatn et al. / Journal of Hospital Infection 105 (2020) 216e224 221
reported to the NAR as such. This will potentially lead to an
underreporting of revision due to infection after THA with
monoblock prostheses, which was addressed by adjusting for
modularity.
Forty of 62 public hospitals were included. Most of the
excluded hospitals performed primary THAs throughout the
whole study period, as did most of the included ones, and with
a completeness of reporting of more than 97% [75]. Time trends
of reporting are therefore not thought to affect the findings.
The reporting of primary THAs was similar in the two groups
(included/excluded) and the distribution of hospital types in
the two groups was also similar (rural hospitals, regional/uni-
versity hospitals, specialized elective hospitals). We therefore
believe that the impact of selection bias is minimal.
In conclusion, UDF ventilation assessed as one encompassing
entity did not influence the risk of revision due to infection
after primary THA compared to CV. When differentiating the
UDF systems on technical specifications, however, primary
THAs performed in ORs with hvUDVF ventilation systems had a
lower risk of revision due to infection compared to ORs with CV.
Considering also that UDF systems can create lower particle
and microbial load than CV systems, our findings support the
use of hvUDVF systems for all ultraclean surgery in the future.
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